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ABSTRACT 
In this thesis, the use of radiation in contemporary interventional cardiology (IC) has 
been investigated. The focus of the study is on patient doses in various minimally 
invasive procedures with higher doses. Patient exposure to radiation can be measured 
with Kerma area product (KAP) and its diagnostic reference levels (DRLs), 
maximum skin dose (MSD) and absorbed organ doses. In this thesis, all three doses 
are explored with accurate and repeatable methods and curiosity toward the causes 
behind the dose level variation. 
KAP results show that the highest patient doses in IC occur in transaortic valve 
implantations (TAVIs) and percutaneous coronary interventions (PCI) with 
significant variation between hospitals and countries. In TAVIs, this variation is 
partly due to the novelty of the procedure, but in PCIs, the need for difficulty levels 
in the DRLs is apparent. The machine learning methodology used in this thesis 
provides insight into how such difficulty levels can be determined and what kinds of 
features they should be comprised of. 
The MSD measurements performed with Gafchromic films show significantly 
higher dose levels in TAVIs than in other procedures and KAP and air kerma alert 
levels were proposed accordingly in Publication 3 of this thesis. The MSD levels 
show a high variance between hospitals and local DRLs were calculated for two of 
the participating hospitals. With the observed variation in respect to both KAP and 
air kerma, a good alternative to these alert levels are automatic skin dose estimations 
provided by the angiosystem manufacturers. In this work, two such algorithms were 
compared to the measured doses and the results were very promising. 
Heart organ dose was measured with radiophotoluminescence (RPL) dosimeters 
and an anthropomorphic phantom in both a computed tomography (CT) scan 
routinely performed before a TAVI procedure and in a typical TAVI procedure. The 
results show that a majority of the dose is caused by the CT scan and that the dose 
from the procedure is relatively low compared to other published results. 
In total, the thesis illustrates good investigative practices in radiation protection, 
their application to IC and results that benefit both contemporary cardiology and 
physicists working in the field. 
KEYWORDS: Radiation dose, cardiology, optimization 
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TIIVISTELMÄ 
Tässä väitöskirjassa on tutkittu säteilynkäyttöä tämän päivän invasiivisessa 
kardiologiassa (IC). Työn painopisteenä ovat olleet potilasannokset erinäisissä 
minimaalisesti kajoavissa toimenpiteissä, joissa käytetään suhteellisen paljon 
säteilyä. Potilasannoksia voidaan määrittää annoksen ja pinta-alan tulolla (KAP) 
sekä sille asetetuilla vertailutasoilla (DRL), maksimaalisilla ihoannoksilla (MSD) 
sekä absorpoituneilla elinannoksilla. Tässä väitöskirjassa mitattiin näitä kolmea 
annosta tarkoilla ja toistettavilla tavoilla. 
KAP tulokset osoittavat, että suurimmat potilasannokset aiheutuvat aorttaläppä-
proteesin katetriteitse tapahtuvassa asennuksessa (TAVI) sekä koronaarisuonten 
pallolaajennuksissa (PCI). Sekä TAVI- että PCI-toimenpiteissä voidaan havaita 
suurta vaihtelua sairaaloiden ja maiden potilasannoksissa. TAVI-toimenpiteissä 
havaittava vaihtelu liittyy osin toimenpiteen uutuuteen, mutta PCI-toimenpiteissä 
havaittava vaihtelu osoittaa tarpeen määrittää vertailutasot toimenpiteiden 
vaikeustasojen mukaan. Tässä työssä käytetty koneoppivaa algoritmia hyödyntävä 
metodologia auttaa hahmottamaan, miten vaikeustasot voi määrittää ja mitä asioita 
niiden tulisi ottaa huomioon. 
Gafchromic-filmeillä tehdyt MSD-mittaukset osoittivat TAVI-toimenpiteissä 
olevan selkeästi muita toimenpiteitä isommat ihoannokset. Tämän johdosta TAVI-
toimenpiteille asetettiin osajulkaisussa KAP- ja ilmakerma-hälytysrajat. Erityisesti 
kahdessa osallistuneista sairaaloista annokset olivat suuria ja niille ehdotettiin 
paikallisia sairaalakohtaisia hälytysrajoja. Suhteessa KAP- ja ilmakerma-annoksiin 
MSD-annosten vaihtelu oli hyvin suurta ja hyvä vaihtoehto hälytysrajoille ovatkin 
angiolaitevalmistajien algoritmit ihoannosestimaateille. Tässä työssä verrattiin 
näistä algoritmeista kahta ja tulokset olivat hyvin lupaavia. 
Sydämen elinannoksia mitattiin radiofotoluminesenssidosimetrialla ja antropo-
morfisella fantomilla rutiinisti ennen TAVI-toimenpidettä tehtävässä tietokone-
tomografiakuvauksessa (CT) sekä tyypillisessä TAVI-toimenpiteessä. Tulokset 
osoittavat, että CT-kuvauksesta aiheutuva annos on toimenpiteen annosta suurempi 
ja toimenpiteen annos on julkaistuihin tutkimuksiin verrattaessa varsin pieni. 
Kokonaisuudessaan väitöskirja havainnollistaa hyviä säteilysuojelun tutkimus-
käytäntöjä, niiden soveltamista invasiiviseen kardiologiaan sekä tuloksia, jotka 
hyödyttävät sekä tämän päivän kardiologiaa että fyysikoita, jotka työskentelevät 
alalla. 
AVAINSANAT: Säteilyannos, kardiologia, optimointi 
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Abbreviations 
ACC/AHA  American College of Cardiology/American Heart Association 
AI  Apical introducer 
Air kerma  Kinetic energy released per unit mass in air 
AP  Anterior-posterior 
AVNRT  Atrioventricular nodal re-entry tachycardia 
BSS  Basic safety standards 
CA  Coronary angiogram 
CABG  Coronary artery bypass grafting 
CH  Central hospital 
CI  Confidence interval 
CINE  cineangiography 
CONCERT European Joint Programme for the Integration of Radiation 
Protection Research 
CRT  Cardiac resynchronization therapy 
CT  Computed tomography 
CTDIvol  CT dose index (volume) 
CTA  CT angiography 
DLP  CT dose length product 
DRL  Diagnostic reference level 
ECG  Electrocardiogram 
EF  Electrophysiological procedures 
ESC  European Society of Cardiology 
EURADOS European Radiation Dosimetry Group 
FL  Fluoroscopy 
FOV  Field of view 
FFR  Fractional flow reserve 
FREG  F-value regression 
FT  Fluoroscopy time 
Gy  Gray 
IAEA  International Atomic Energy Agency 
IC  Interventional cardiology 
IEC  International Electrotechnical Commission 
IVUS  Intravascular ultrasound 
KAP  Kerma area product 
kV  Kilovolt 
LAO  Left anterior oblique 
LAT  Lateral 
mAs  Milliamperesecond 
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MEDIRAD Implications of Medical Low Dose Radiation Exposure 
MIR  Mutual information regression 
MOSFET  Metal oxide semiconductor field effect transistor 
MSD  Maximum skin dose 
MSE  Mean squared error 
MSURF  MultiSURF 
MSURFS  MultiSURFstar 
NA  Not applicable 
NRD Net reflective density 
OCT  Optical coherence tomography 
OID  Object image distance 
PKA  Product of kerma and area, KAP 
PC  Pigtail catheter 
PCI  Percutaneous coronary intervention 
PEAR  Pearson correlation coefficient 
PET  Positron emission tomography 
PI  Pacemaker implantation 
RAO  Right anterior oblique 
RBF  Radial basis function kernel 
RELF  ReliefF 
RF  Radiofrequency 
ROI  Region of interest 
RPAK  Reference point air kerma 
RPL  Radiophotoluminescence 
RQR  Radiation quality of radiation beam 
SID  Source image distance 
SOD  Source object distance 
SPEA  Spearman's correlation coefficient 
SURF  SURF 
SURFS  SURFstar 
Sv  Sievert 
SVR  Support vector regression 
STUK  Säteilyturvakeskus, Radiation and  
Nuclear Safety Authority of Finland 
TAVI  Transaortic valve implantation 
TLS  Thermoluminescence dosimetry 
TPW  Temporary pacing wire 
TOE  Transoesophageal echo 
UH University hospital 
US  Ultrasound 
VERIDIC Validation and estimation of radiation skin dose in interventional 
cardiology  
 
 
  
 10
List of Original Publications 
This dissertation is based on the following original publications, which are referred 
to in the text by their Roman numerals. In addition, the thesis contains unpublished 
results on patient organ dosimetry. 
I Järvinen J, Sierpowska J, Siiskonen T, Järvinen H, Kiviniemi T, Rissanen T, 
Matikka H, Niskanen E, Hurme S, Larjava HRS, Mäkela TJ, Strengell S, 
Eskola M, Parviainen T, Hallinen E, Pirinen M, Kivelä A, Teräs M. 
Contemporary Radiation Doses in Interventional Cardiology: a Nationwide 
Study of Patient Doses in Finland. Radiation Protection Dosimetry, 2019; 1-
11, ncz041. 
II Siiskonen T, Ciraj-Bjelac O, Dabin J, Diklic A, Domienik-Andrzejewska J, 
Farah J, Fernandez JM, Gallagher A, Hourdakis CJ, Jurkovic S, Järvinen H, 
Järvinen J, Knežević Ž, Koukorova C, Maccia C, Majer M, Malchair F, 
Riccardi L, Rizk C, Sanchez R, Sandborg M, Sans Merce M, Segota D, 
Sierpowska J, Simantirakis G, Sukupova L, Thrapsanioti Z, Vano E. 
Establishing the European diagnostic reference levels for interventional 
cardiology. Physica Medica, 2018, 54: 42-48. 
III Järvinen J, Sierpowska J, Siiskonen T, Järvinen H, Kiviniemi T, Rissanen T, 
Matikka H, Niskanen E, Hurme S, Larjava HRS, Mäkela TJ, Strengell S, 
Eskola M, Parviainen T, Hallinen E, Pirinen M, Kivelä A, Teräs M. 
Contemporary Radiation Doses in Interventional Cardiology: a Nationwide 
Study of Maximum Skin Doses in Finland. Radiation Protection Dosimetry, 
2019; 1-10, ncz273. 
IV Suomi V+, Järvinen J+, Kiviniemi T, Ylitalo A and Pietilä M. Exhaustive 
feature selection for predicting KAP radiation dose in coronary angiographies 
and percutaneous coronary interventions. Computers in Biology and 
Medicine, 2020; 120, 103725. 
+These authors contributed equally to this work. 
The original publications have been reproduced with the permission of the copyright 
holders. 
 
 11 
1 Introduction 
The use of radiation in medicine is common and its uses are both numerous and 
highly variable (STUK, 2019). Many of the current uses are ionizing, which means 
that their use causes harm and is carefully regulated. One of the most intensive uses 
of radiation in medicine occurs during long angiographic procedures (Wall and Hart, 
1997) that generally diagnose problems with minimally invasive techniques. In 
interventional cardiology (IC), all procedures have either a diagnostic or therapeutic 
function and are becoming more and more numerous and complex (Blackledge and 
Squire, 2009; Fokkema et al., 2013; Kiviniemi et al., 2016). 
The cardiological use of radiation is generally considered to be well-justified 
with immense and direct benefits, but not entirely without issues with optimization 
(e.g. Picano and Vano, 2011). With multiple diseases that can be diagnosed with life-
saving or changing implications, there is no question as to the value of using 
radiation in IC, but the question of how much should be used is one that can never 
be entirely solved. Optimizing use of radiation in IC diminishes risks of cancer and 
skin damage for the patient as well as for the cardiologists, radiographers and nurses 
in the angioroom. With an ageing patient population and changes in work habits and 
technology, optimization in IC is currently more important than ever. 
Internationally, interest in radiation doses in cardiological procedures continues 
to be enthusiastic (Klein et al., 2009; Knuuti and Järvinen, 2014; Sun et al., 2013) 
and there have been multiple studies on dose optimization in cardiological 
procedures (Klein et al., 2009; Rehani, 2007). With sufficient, easily accessible 
information such as distributed and readily available guidelines, this concern is 
developing into a more robust culture of dose hygiene – one with regular quality 
assurance and dose optimization from both technological and practical aspects. 
Concurrently with this work, such guidelines were prepared by the Radiation and 
Nuclear Authority in Finland (STUK) (Järvinen et al., 2018a). 
In this thesis, the contemporary practice of cardiological use of radiation in 
angiographic procedures is explored. In particular, patient stochastic and 
deterministic risks, as well as possible ways of minimizing them without impacting 
patient safety in terms of complications are delved into. The thesis comprises four 
different publications on patient Kerma area product (KAP), features predicting 
Jukka Järvinen 
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them, skin doses and unpublished results on patient organ (heart) dosimetry in a CT 
heart scan and a TAVI procedure. In the following review of literature (Chapter 2), 
relevant concepts such as central cardiological procedures and factors that affect the 
use of radiation in them are introduced. In the later chapters, the aims of the study 
(Chapter 3), the collected data and methods (Chapter 4), results (Chapter 5), 
discussion (Chapter 6), and conclusions (Chapter 7) are presented. 
 
 13 
2 Review of the Literature 
2.1 Cardiological diseases and angiographic 
procedures 
The most common cardiological diseases that are diagnosed and, to an extent, treated 
with procedures, comprise of coronary diseases, arrythmias or electrophysiological 
diseases and structural malfunctions, such as in the valve (Steinberg et al., 2010). 
Relatively recently, many cardiological procedures have become increasingly 
common (Blackledge and Squire, 2009; Fokkema et al., 2013; Kiviniemi et al., 
2016).  
In an IC procedure, patients are diagnosed or treated using fluoroscopy guided 
methods. Commonly, the procedure is performed using either femorally or radially 
inserted catheters, which are then imaged and used for various diagnostic and 
treatment purposes. During the procedure, the patient is imaged with fluoroscopy 
and Cine series with the cardiologist and assistant typically standing right next to 
them. A photo of an angioroom in Turku Heart Centre is shown in Figure 1. In 
general, the procedures are minimally invasive but, if necessary, they can be changed 
to surgical procedures. Pacemaker implantations form an excemption as they require 
minor surgery.  
Cardiological diseases are treated with multiple methods with drug treatment 
being the most common and surgery being reserved only for patients for whom other 
treatments are not sufficient. Focus is also traditionally given to providing guidance 
on how to live healthy to increase quality of life; specifically the European Society 
of Cardiology (ESC) lists the following lifestyle choices as factors that significantly 
lower the risk of cardiological disease (ESC, 2012): 
• No use of tobacco. 
• Adequate physical activity: at least 30 minutes ve times a week. 
• Healthy eating habits. 
• No overweight. 
• Blood pressure below 140/90 mmHg. 
• Blood cholesterol below 5 mmol/L (190 mg/dL). 
Jukka Järvinen 
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• Normal glucose metabolism. 
• Avoidance of excessive stress. 
 
Figure 1.  Photo of an angioroom in Turku Heart Centre. The room has capabilities for coronary, 
electrophysiological and TAVI procedures as well as pacemaker implantations. Inside 
the room, there are multiple radiation shields for personnel. The angiodevice in the photo 
is Philips Azurion 7 C 12. 
2.1.1 Coronary diseases and their treatment 
Coronary disease is the most common cause for cardiological procedures. In a 
coronary disease, occlusion in the coronary arteries causes insufficient blood flow, 
which can cause a lack of oxygen in the heart tissue, leading to an infarction (Ashley 
and Niebauer, 2004). Occlusions can often be diluted with drugs, but if their effect 
is not sufficient, the patient eventually undergoes a coronary angiography (CA). 
During CA, blood flow in the coronaries is diagnosed in pulsed X-ray imaging with 
a suitable iodine-based contrast agent to enhance visibility of blood flow in the 
coronaries. If the patient's diagnosis requires it, CA is often immediately followed 
by percutaneous coronary intervention (PCI), in which stenotic or occluded 
coronaries are cleared or expanded with a balloon or other stenting device as 
illustrated in Figure 2. PCI can be performed immediately (ad hoc) or electively. The 
Review of the Literature 
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alternative to PCI is bypass surgery (CABG), which is considered superior in 
multivessel occlusions, but it carries more significant risks due to its invasive nature 
(Sipahi et al., 2014). 
 
Figure 2.  Illustration of percutaneous coronary intervention in a stenotic coronary artery. The stent 
is placed at the stenotis and the inserted balloon is inflated and retrieved. After three 
months from the procedure, blood flow is normalized (Oberhauser et al., 2009). 
2.1.2 Arrhythmias and their treatment 
Arrhythmias, or abnormal heart rhythms, are caused by changes in the sequence of 
the heart's electrical impulses. Most arrhythmias are not treated, as they do not pose 
a signicant threat or harm to the quality of life. To varying extents, arrhythmias can 
be treated with medication, electrophysiological procedures or pacemakers. One of 
the main motivations to increasingly treat them is that they have been recognized to 
increase stroke risk (Engström et al., 2000). Treatment is chosen on an individual 
basis based on multiple factors, but it can be briefly summarized as being mainly 
dependent on the type of arrhythmia, frequency and duration of attacks and patient 
age and condition. 
X-ray-guided electrophysiological procedures are performed for only select 
types of arrhythmias that can be dangerous if the patient develops or has a coronary 
Jukka Järvinen 
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disease. The procedures generally consist of surface and intracardiac ECG 
monitoring, triggering of the arrhythmia, and its treatment. Intracardiac ECG is 
performed by guiding catheters into the right atrium, coronary sinus, HIS bundle, 
and the apical right ventricle (Josephson, 2008). Once the catheters are in place, 
arrhythmia is induced by burdening the heart with fast pacing. If the arrhythmia 
begins, its origin and pathways can be determined. Within the pathways, electrical 
impulses circulate and cause the muscles to contract and induce the arrhythmia. 
Arrhythmia's treatment can generally be either lifestyle guidance, medicinal or 
electrical cardioversion, or a suitable procedure. An increasingly common treatment 
is ablation, in which critical pathways for the electrical signal are ablated with a 
(radiofrequency) RF-catheter or a heat-absorbing cryoablation catheter in direct 
contact with the tissue. These techniques provide comparable results, and for the 
physician, the main differences are in the ease of use and size of the ablation area. 
(Kuck et al., 2016) 
Atrioventricular nodal re-entry tachycardia (AVNRT) is a supraventricular 
tachycardia, which means that it originates above the HIS bundle and causes an 
abnormally high heart rate. AVNRT is caused by the circulation of an electrical 
impulse in or around atrioventricular node, which is created by a reentry circuit as 
the impulse travels in two pathways at varying speeds. AVNRT, if especially 
frequent or combined with coronary disease, can require catheter ablation. (Cadogan, 
2014; Haissaguerre et al., 1989) 
Atrial flutter is a supraventricular tachycardia that is caused by a reentry circuit 
in the right atrium. The resulting tachycardia is typically within 200-400 bpm. As 
with AVNRT, the other pathway can be cut with ablation. (Daoud and Morady, 
1998; Lee et al., 2005) 
Pacemaker implantations, as the term implies, refer to installations of various 
kinds of pacemakers. All types of pacemakers significantly impact patient's quality 
of life and are typically the last non-conservative treatment offered for arrhythmias. 
The most common kinds are one and two chamber pacemakers (Furman et al., 1989, 
p.261). During an implantation, leads are taken to the right ventricle, right atrium, or 
both. The leads measure and deliver electrical signals from these locations to the 
device, which is typically implanted under the skin in the chest, below the collar 
bone. It is programmed to perform in accordance with the patient's own rhythm, with 
various possibilities for sensing and therapy. Typically, radiation is only needed to 
guide the implantation and document various stages of the procedure. 
Implantation of biventricular Cardiac Resynchronization Therapy (CRT) devices 
is often considered significantly more challenging as an additional lead is taken into 
the coronary sinus for left ventricular pacing (Airaksinen et al., 2016, p.748). CRT's 
are implanted in a case of more severe heart failure where both ventricles need to be 
paced for synchronized functioning. 
Review of the Literature 
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2.1.3 Structural malfunctions and their treatment 
Although the definition is relatively new [introduced in 1999 by Martin Leon 
(Steinberg et al., 2010)], structural heart diseases comprise a number of various 
diseases. The most novel and, as such, perhaps the most important procedures in the 
IC use of radiation are transaortic valve implantations (TAVI) (Airaksinen et al., 
2016, p.833), which consist of implanting a prosthetic aortic valve with a catheter to 
replace a malfunctioning valve. Typically, the malfunction is caused by severe aortic 
stenosis. The prosthesis can be placed using various approaches. In the transapical 
approach, the left ventricular apex is located using angiography, an incision is made 
close to the apex of the heart, and the pericardium is punctured. The valve is then 
inserted with an introducer and opened, e.g., with an inflatable balloon (Cheung and 
Lichtenstein, 2012). Opening a TAVI prosthesis is shown in Figure 3. 
Another common TAVI approach is transfemoral (Cribier et al., 2009), in which 
the catheter is guided to the aortic valve via the femoral artery. Due to its less 
invasive nature, it is preferred to the transapical approach when possible (Bapat et 
al., 2012). However, the need for fluoroscopy is often significantly higher, and there 
can be problems with visibility of the prosthesis. A third common technique is 
transaortic, in which the valve is guided through the ascending aorta (Bapat et al., 
2012). 
 
Figure 3.  Opening of a TAVI prosthesis. (a) Collapsed stent over a guidewire via the apical 
introducer (AI). A pigtail catheter (PC) can also be seen in the aortic root, in addition to 
a right ventricular, temporary pacing wire (TPW) and a transoesophageal echo (TOE) 
probe. (b) The expanded prosthesis in place. (Clayton et al., 2013). 
Jukka Järvinen 
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Other structural malfunctions that can be treated with minimally invasive procedures 
include, for example, the treatment of mitral valve stenosis (Chmielak et al., 2017) 
or regurgitation (Sherif et al., 2016) and left atrial appendage occlusion to prevent 
the formation of thrombus (Lund et al., 2012). These procedures are mainly 
ultrasound-guided and, thus, the use of ionizing radiation in them is minimal. 
2.2 Use of radiation in cardiology 
The most important factor in how radiation is used in modern IC is enabling and 
assisting in various procedures and minimizing risk of complications, including 
those due to use of radiation itself. IC procedures are minimally invasive, and to 
succeed, they require a multitude of information on patient physiology and anatomy 
and procedure status. This information can, to an extent, be acquired with various 
techniques and devices such as electrocardiogram, ultrasound, esophageal 
ultrasound, intravascular ultrasound (Mantziari et al., 2011), infrared optical 
coherence tomography (Terashima et al., 2012) or fractional flow reserve for 
coronary blood pressure measurement (Mehra and Mohan, 2015), but for most 
cardiological procedures, good-quality X-ray images are essential. 
The use of radiation in medicine has three basic principles: justification, 
optimization and dose limitation (ICRP, 2007). All use of radiation should have a 
realistic expected benefit that outweighs the harm caused by the radiation. In IC, 
cardiological diseases are first diagnosed using information collected with 
electrocardiograms (ECG), blood pressure tests, blood tests, US, computer 
tomography (CT) or isotope imaging such as positron emission tomography (PET) 
(Camm et al., 2009). This vast amount of information translates to the careful 
assessment of each procedure's justification: risks of various complications, cancer 
or skin damage and probability of success. 
In IC, patient radiation dose is measured with maximum skin dose (MSD) and 
KAP. MSD is defined as the maximum dose in a 1 cm2 on the skin and, due to 
difficulties in measuring it, increasingly estimated during procedures. KAP on the 
other hand designates output radiation multiplied by irradiated area and is 
automatically either measured or calculated with precision mandated by law 
(Sosiaali- ja terveysministeriö, 2018). In angiodevices, KAP is typically calculated 
based on x-ray tube output parameters and field of view (FOV). 
During IC procedures, contrast agent is utilized to increase visibility of arteries 
and veins, and radiation is used in pulses with either fluoroscopy (FL) or 
cineangiography (cine) modes. FL refers to low-dose and low-image quality 
placement of catheters and cine to series of images taken with significantly higher 
dose and better image quality. During procedures, cardiologists can vary pulse rate 
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and choose from typically several templates of varying image quality and dose rate 
for the given procedure. 
During cardiological procedures, the X-ray tube angle or projection is 
typically changed frequently for optimized visibility. This workflow results in 
multiple entry points for the radiation beam and significantly reduces the MSD. 
However, oblique or lateral projections increase the KAP, as more tissue needs to 
be penetrated. The effect on total KAP depends on improved visibility of the 
regions of interest (ROI). 
Based on the size of the ROI, the x-ray field can also be collimated, or the ROI 
can be zoomed into. Whereas collimation limits the size of the irradiated area, the 
zoom also enlarges the image on the screen and increases its quality by increasing 
the amount of radiation used for generating it. How much zoom increases it depends 
mainly on how the angiosystem has been preprogrammed and the level of zoom. 
Traditionally, fluoroscopy time (FT) has been used to describe the use of 
radiation in procedures. However, due to the difference in dose levels between cine 
and FL, the settings for image quality, zoom, collimation and projection choices, its 
effect on total KAP is complex, and its use as a diagnostic reference level (DRL) in 
angiographic procedures is no longer recommended by the International 
Commission on Radiation Protection (ICRP) (ICRP, 2017). 
The use of radiation in cardiology is not entirely limited to IC. Especially with 
recommendations of CT angiographies (CTA) by the European Society of 
Cardiologists (ESC) (ESC et al., 2013), and with more and more prevalent PET 
imaging of the heart, a significant amount of radiation to the heart is delivered 
outside of angiorooms. 
2.2.1 Physical properties of radiation and its biological risks 
Harm to the patient can be divided into stochastically increased cancer risk (Lin, 
2010), commonly calculated from the KAP and the risk of deterministic skin 
damage at the entry point of the radiation. Ionizing radiation has three possible 
scenarios when traveling in a medium: it can pass through, scatter or be absorbed. 
All three of these phenomena are dependent on the density of the matter and energy 
of the radiation. When radiation passes through a patient, it can be absorbed by the 
detector and becomes data in the resulting image. Contrast in the image is due to 
differences in the density of the matter, which affect the amount of absorbed and 
scattered radiation. When radiation is scattered, its path deviates, and amount of 
noise in the resulting image is increased. In addition, scattering is the reason that 
all facilities using radiation need to be shielded. This need for shielding also 
applies to all personnel present inside the shielded area while radiation is used, 
e.g., in procedures. 
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Radiation from an X-ray tube has a maximum energy controlled by tube voltage. 
An example of an energy spectrum for an X-ray tube with a typical tungsten cathode 
is illustrated in Figure 4. The more energy the X-ray photons have, the better they 
penetrate matter. Copper or aluminum filtration is used to absorb much of the lower-
energy radiation and prevent it from reaching the patient, but nonetheless, a 
significant portion of radiation is absorbed at its entry point – the patient's skin. 
Besides radiation energy, MSD is affected by the procedure's total KAP and 
projections used in it. Whereas patient cancer risk is a statistical effect with a 
multitude of factors and relatively rare occurrence, patient skin damage due to MSD 
is a deterministic effect.  
 
Figure 4.  Illustration of radiation energy spectrum for a typical tungsten anode for 80 and 100 kV. 
The drop in the amount of x-rays at low energies is due to filtration. 
When absorbed, energy from the radiation may cause molecule ionization, further 
causing physical and chemical reactions in the matter. In a cell, direct ionization or 
these indirect reactions can harm DNA strands, possibly causing the cell to mutate. 
For example, in a PCI procedure, the absolute increase in cancer risk is estimated to 
be roughly 0.02% for typical cardiological patients (Vijayalakshmi et al., 2007). 
Besides the procedure, a relative increase in cancer risk also accounts for patient age 
and gender, as illustrated in Figure 5. Cancer risk estimations with effective doses 
should not be used for individual purposes due to the imprecision of tissue weighting 
factors and the estimations included in them (Dietze et al., 2009; Fisher and Fahey, 
2017). 
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Figure 6 depicts how the probability of patient harm depends on the dose 
received. According to the model shown, even small doses are assumed to increase 
cancer risk, whereas the deterministic skin damage has a clear threshold (Paile, 2002, 
Chapter 3). Commonly, this threshold is estimated as 2 Gy for early transient 
erythema (Balter et al., 2010). 
 
Figure 5.  Illustration of age and gender dependency of cancer risk in radiological examinations 
and procedures (Foffa et al., 2009). 
 
Figure 6.  Illustration of how stochastic (black) and deterministic (green) harm to patient depend 
on dose level (Paile, 2002, Chapter 3).  
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2.2.2 Optimizing the use of radiation 
As mentioned above, the use of radiation in medicine is commonly both justified and 
reasonably safe for the individuals in question. However, the use of radiation in 
medicine is never completely optimized. With a human being the final observer of 
the x-ray image, some level of subjectivity as to what constitutes sufficient image 
quality is always present. In cardiological procedures, optimization relies on multiple 
aspects of the procedures and is difficult to assess thoroughly (ICRP, 2007). 
Compared to diagnostic imaging, the use of radiation in procedures is always more 
situational and is based on instantaneous and learned continuous decisions. In 
addition to patient anatomy, hospital working habits and the physician's skill, what 
exactly is carried out in the procedure and procedure-specific physiological changes 
affect the need for FL and cine. For newer procedures such as TAVI, what steps are 
taken during the procedures is also liable to change with time (Kaier et al., 2017). 
With a realistic view of the contemporary practice, necessary changes in the 
practice can be introduced. In cardiology, these changes can include the careful 
assessment of the cardiologists' working habits, optimization of the angiographic 
system's image quality or a more thorough assessment of the system's capability and 
functioning. The central aspects in all optimizations are the availability of relevant 
data and motivation of the personnel. 
Optimizing radiation use in cardiological procedures can be measured, to an 
extent, by patient KAP. To optimize KAP and to know what level is realistically 
achievable, reference points are needed. These can be, and in some instances are, 
requested from other hospitals performing similar procedures, but diagnostic 
reference levels (DRLs) (ICRP, 2017) are preferable. 
As stochastic risks from the use of radiation in IC procedures are typically 
considered to be justified and outweighed by the benefits of the procedure, 
consideration of the dose limitation under normal, accordingly optimized 
circumstances in IC is a serious concern, mainly with pregnant or young patients, 
along with procedures with significant risk of deterministic skin damage. However, 
with an increasing number and complexity of IC procedures, dose limitation should 
also be applied to staff due to their slow-but-steady exposure to small doses of 
radiation and associated cancer and cataract risks (Vano et al., 2010). Besides patient 
dose, staff doses are affected by numerous factors, such as the use of shielding, 
distance from the patient and projection. In Finland, guidelines for IC staff were 
published by the STUK in 2018 (Järvinen et al., 2018a). 
2.2.3 Diagnostic reference levels 
The recommended methodology to set DRLs is to gather a sufficient amount of data 
from multiple hospitals and take a third quartile of their medians (ICRP, 2017). This 
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methodology can produce significantly lower levels than if the third quartile were 
taken from the total data (Georges et al., 2016). 
Diagnostic Reference Levels (DRLs) offer a reliable basis for optimizing the use 
of radiation and are easy to rely on (ICRP, 2017). Historically based on dose surveys 
by the United Nations Scientific Committee on the Effects of Atomic Radiation 
(UNSCEAR), the concept of investigation levels was first proposed by ICRP in its 
1990 recommendations (Wall et al., 1998). These days, the guidelines for DRLs are 
posed by the ICRP as recommendations, and their use is relatively free and manifold. 
In Finland, DRLs have traditionally been set by the STUK, but it is likely that some 
will be posed regionally by the EU in the future. Regional levels require significant 
international coordination and cooperation. As such, the involvement of either 
national or international organizations can be seen as a requirement, even if only for 
their network connections. 
At the ground level, local DRLs also exist in many hospitals for various 
examinations and procedures, (Saukko et al., 2017, e.g.). Local DRLs cannot be 
higher than the existing national DRLs, and they apply only to the data from a 
specific hospital. However, they also offer valuable information and comparison 
material to other hospitals. In addition to national centers for radiation protection and 
ground-level hospitals, also the International Atomic Energy Agency (IAEA) utilizes 
the ICRP recommendations for basic safety standards and their better 
implementation. 
Traditionally, DRLs serve to set a level of comparison for the current level of 
radiation used in diagnostic imaging. Despite some challenges related to larger 
variations, the same concept translates well to cardiac procedures. Setting a 
comparison point increases awareness about the issue and encourages action. DRLs 
set the organization up to aim for and assign resources to specific targets. In 
cardiology, realistic and specific DRLs and subsequent dose comparisons provide 
the cardiologists with incentives and regular reminders to be concerned about the 
radiation dose. 
DRLs can be set for any numerical parameter relevant to a study or procedure, 
but generally, KAP is considered the most suitable for optimization purposes. For 
cardiological procedures in Finland, the first DRLs were KAP and FT levels set in 
2006 for CA (60 Gy·cm2 and 8 min) and PCI (100 Gy·cm2 and 20 min) (STUK, 
2005). Other contemporary DRL publications include the French 2nd RAY'ACT from 
2017, which reported 26 Gy·cm2 DRL for CA and 60 Gy·cm2 DRL for PCI and the 
Swiss DRLs for CA (50 Gy·cm2), PCI (100 Gy·cm2), PI (5 Gy·cm2), 
electrophysiological procedures (EF, 20 Gy·cm2) and TAVI (100 Gy·cm2). Based 
on the data used in Publication I of this study, new DRLs were published in 2016 
(STUK, 2016). 
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In recent years, some DRLs such as Finnish DRLs for childrens' CT 
examinations (STUK, 2015) have been published as a function of patient weight. 
The main motivation for this is the huge variation in children's size and the well-
known relationship between patient size and the required amount of radiation; with 
bigger patients, more of the dose is absorbed and scattered, so more is needed for a 
good image quality. For interventional procedures, a similar variation is notable, but 
the cause is complex. For some time now, the ICRP has recommended the use of 
difficulty levels [the latest being (ICRP, 2017)] and this was one of the main 
motivations for Publication 1. For cardiological procedures, the difficulty of a PCI 
is described to some extent by the American Heart Association/American College of 
Cardiology (AHA/ACC) score for lesion classication (Ellis et al., 1988, 1990; Ryan 
et al., 1988), but no other procedures have such scores. The central criteria of the 
score are tortuosity of the vein, location, size and density of the thrombus and age of 
total occlusion. In addition, the AHA/ACC score's suitability for describing how 
much radiation is required is questionable. 
With the perceived variation in procedure DRLs, the comparison to DRLs and 
their application should be handled with care. The possible exceeding should not be 
reacted to by altering of the image quality too much but rather by comparing the 
procedure methodology and the many aspects relevant to the procedures instead as 
an incentive to find out why the exceeding occurs and how dose optimization should 
be carried out. 
2.2.4 Maximum skin dose dosimetry and alert levels 
The radiation dose to patient skin can cause various levels of harm, depending 
mainly on the amount of radiation and its energy. Skin exposure limits and their 
assessment are mandated by the IAEA in its basic safety standards (BSS) directive 
(IAEA, 2014). As mentioned above, X-ray beam filtration significantly reduces skin 
dose. Deterministic harm to a cardiology patient's skin can be most reliably measured 
in 2D with reflective Gafchromic film dosimetry (Amano et al., 2002, 2003). Placed 
under the patient, these films absorb a slight amount of the passing radiation and 
darken with respect to how much radiation they absorb (Farah et al., 2015). After 
irradiation, films are scanned and the measured film darkening is compared to 
carefully produced calibration fits to obtain an estimate for the irradiated dose. The 
uncertainty of Gafchromic film dosimetry has been proposed to be 20% by Farah et 
al (Farah et al., 2015). 
Gafchromic film accuracy requires careful calibration, maintenance and analysis 
of the films. As such, they are not suitable for clinical practice. Even so, they function 
as a gold standard for skin dosimetry and enable setting alert levels for KAP, so that 
routines can be formed for diminishing MSD, when the KAP alert level is exceeded. 
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Typically such action includes recommending projections which do not result in dose 
to the location of MSD, limiting the use of cineangiography (Cine) or, in extreme 
cases, resolving to continue the procedure at another date. 
Contemporary evaluations of patient skin doses in cardiology are scarce and 
relatively old, ranging from 2003 to 2014. For PCI, mean and median skin doses 
range from 0.5 to 1.3 Gy. Very little data on TAVI skin doses have been published. 
A novel method for skin dose estimation are angiosystem specific calculation 
methods such as GE DoseWatch (GEMS, Milwaukee, WI), Siemens CareMonitor 
(Siemens Healthcare, Erlangen, Germany), Canon Dose Tracking System (Canon 
Medical Systems, Otawara, Japan) and Philips DoseWise (Philips Healthcare, 
Amsterdam, Netherlands). In addition, vendor neutral software such as DOSE 
(QAELUM, Leuven, Belgium) and Em.dose (esprimed SAS, Villejuif, France) exist 
for this task. These monitoring softwares account for various live information such 
as tube angulation, energy and amount of radiation at each angulation and location 
of the patient table to estimate MSD and its location with the maximum reference 
point air kerma (RPAK). As such, their accuracy depends on the largely unpublished 
included information but also on the algorithm processing it and how the result is 
presented. For example, DoseWatch presents the information as a map whereas 
CareMonitor displays only the maximum value. Already on the market, they provide 
an easily interpreted real-time estimate of MSD and, commonly, also its location on 
the patient skin. 
2.2.5 Organ dosimetry 
Patient organ dosimetry is perhaps most commonly performed with passive solid-
state dosimeters, either attached to a patient or more commonly inside a phantom. 
Passive dosimeters measure the dose by absorbing energy proportional to the amount 
of radiation. Today, the most common dosimeters in Finland are 
radiophotoluminescence (RPL) dosimeters (Manninen, 2014), thermoluminescence 
dosimeters (TLD) (McKeever et al., 1995) and metal oxide semiconductor field 
effect transistor (MOSFET) dosimeters (Chida et al., 2009). 
With TLD, radiation is captured inside a crystal and released as light when 
heated. TLD crystals are very small and, depending on the material, are suitable for 
many radiation energies. However, the angular dependency of traditional TLDs is 
significant (Jin et al., 1992), making them a less ideal option for procedures or 
examinations with multiple projections. MOSFET dosimeters were originally 
developed for radiation therapy and have only relatively recently been proven 
suitable for diagnostic energies (Kaasalainen, 2015). 
In RPL dosimeter materials, electrons transferred to the conduction band by 
ionizing radiation migrate into deep traps. These deep traps are earth or transition 
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metal (i.e., silver) ions doped as impurities into the phosphate material. The 
proportioned trap can then be photoexcited without the electron being erased back 
into the conduction band (Riesen and Liu, 2012). As such, RPL dosimeters can be 
repeatedly read out by photo excitation without fading in the signal per reading. Of 
these potential methods, RPL dosimetry was chosen to be used in this thesis based 
on availability and accuracy. RPL dosimetry has good accuracy and repeatability at 
low doses (20 µGy - 11 mGy) with an average coefficient of variation between 0.5% 
and 6% (Hsu et al., 2007, 2006; Lee et al., 2009; Manninen et al., 2012; Rah et al., 
2009). The energy response of RPLDs is linear between 50 and 125 kVp with a 2.9% 
mean error (Manninen et al., 2012) and the method's angular dependence is very 
good up to 30 degrees (Manninen et al., 2012). 
Besides measuring, organ doses are also commonly estimated using Monte Carlo 
calculations (Andreo, 1991). In Monte Carlo methods, each x-ray and their target are 
simulated with probabilities given for each interaction. One such widely used 
software is PCXMC (STUK, Helsinki, Finland) (Servomaa and Tapiovaara, 1998). 
2.2.6 CT imaging 
CT imaging is a topic of recent doctoral dissertations (e.g. Kaasalainen, 2015; 
Niiniviita, 2017), and due to its minor role in this thesis, only a small glimpse is 
provided here. As mentioned above, cardiological use of radiation is no longer 
limited to only IC, but common diagnostic studies such as pre-procedure TAVI CT 
scan also contribute to patients' total dose. CT imaging is performed using CT 
scanners with the patient lying down on the scanner table and the X-ray tube and 
curved detectors rotating around the patient inside a gantry. In a volume scan, the 
patient table is stationary during imaging, whereas in a helical scan, the patient table 
moves. Both types of scans can be used for the imaging of longer areas due to 
sophisticated algorithms calculating the resulting 3D images and sets of 2D images. 
CT radiation doses are typically described with the CT dose index (CTDIvol) and 
dose length product (DLP), which is calculated as CTDIvol multiplied by the length 
of the imaged area. 
For heart imaging, CT scans are often performed phased, i.e. ECG gated, to 
control for and minimize the effect of movement. ECG gating is performed by 
collecting ECG data during the scan and prospectively triggering the scan at certain 
phases or retrospectively filtering it using only the suitable phase for reconstruction 
of the images. The most common phases are arterial and venous phases and their 
timing depends on the scanned body area. Respiratory movement is typically 
minimized by performing the scan in a breath hold. 
With the ease and speed of scanning, relatively modest price and highly 
repeatable diagnostics, CT imaging has become prevalent, and its doses have long 
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been considered relatively high (Niiniviita, 2017). This has served as great 
motivation for dose optimization for both medical physicists and CT manufacturers. 
The most significant technological advancements in CT imaging have been 
improvements in iterative calculation for better image quality and dose saving; the 
speed of scanning, either with improved coverage or a faster scanning area 
movement for better temporal resolution of repeated dynamic imaging; and spectral 
or dual energy imaging for the resolution of selected material compositions. 
2.3 Big data and data mining 
Similarly to CT imaging, big data and data mining are vast topics, and only a glimpse 
is offered here to illustrate the scope of how they were touched upon in the thesis. In 
medical practice, as diagnosis and treatment decisions gradually move toward 
evidence-based medicine (Sackett et al., 1996), data behind the evidence and its 
analysis and interpretation become more and more important. As such, interest in 
big data and data mining is growing with a trove of possible applications in 
healthcare (Beam and Kohane, 2018). One of those methods is machine learning, 
and one of the applications is optimizing the use of radiation; in particular, the above 
mentioned difficulty levels can be seen as a suitable application. Machine learning 
is considered a subset of artificial intelligence. Similarly, deep learning is considered 
a subset of machine learning. 
In general, machine learning algorithms focus on handling big data in an 
objective, reliable and repeatable way, offering insight into predicting how the data 
will behave in the future. Machine learning algorithms require training, during which 
they are provided sufficient data and means to classify it with a loss function. By 
splitting the data repeatedly into random training and testing data sets, the machine 
learns to optimize the classification by minimizing the loss function, simultaneously 
assessing its own performance. Applying statistical significance to machine learning 
is a complex topic (Drummond and Japkowicz, 2010) and is out of the scope for this 
thesis. Machine learning algorithms are very dependent on the representativeness of 
the training data. 
An example of a suitable machine learning model for dose prediction with 
difficulty levels is support vector regression (SVR), a supervised machine learning 
model that predicts continuous output values (i.e., real numbers) by minimizing a 
pre-defined loss function. Due to convention, machine learning algorithms refer to 
included parameters as features, and in appropriate parts this convention is also 
applied in this thesis. 
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3 Aims 
The main aim of this thesis is to answer the need to evaluate doses and minimize 
risks related to the use of radiation in contemporary cardiological procedures, with 
an emphasis on newer or more complex procedures such as TAVI and PCI. In the 
Publications, this was done by a thorough investigation of patient KAP in 
Publications I, II and IV and skin doses in Publication III. The main questions were: 
• What is the current level and variation of use of radiation in cardiology in 
Finland and in Europe? 
o What is the contemporary level of use of radiation in cardiology in 
Finland and Europe? 
o How high is the KAP variation and what demographic and clinical 
factors predict KAP? 
• Is patient skin damage possible in contemporary cardiac procedures?  
o If so, what kinds of alert levels for possible skin damage should be 
set? 
o How accurate are the available automatic skin dose estimating tools 
GE DoseWatch and Siemens CareMonitor? 
• At what level are heart organ doses in TAVI procedures and the prerequisite 
CT scans in Turku University Hospital? 
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4 Materials and Methods 
4.1 Patient KAP doses 
4.1.1 Finnish and European DRLs 
In Publication I, data from five university hospitals and two central hospitals in 
Finland were analyzed to explore the contemporary use of radiation in cardiological 
procedures. Namely, the Turku, Helsinki, Tampere, Kuopio and Oulu University 
Hospitals and Joensuu, Jyväskylä and Vaasa Central Hospitals participated in the 
study. These hospitals were coded as UH1-5 (university hospital) and CH1-3 (central 
hospitals. The data were collected between 2014 and 2016 for both scientific 
research purposes and to provide the STUK with the necessary data for new DRLs. 
As such, the study was performed in close collaboration with the STUK. At the time 
of data collection, electrophysiological and TAVI procedures were performed only 
in the university hospitals. Since then, some central hospitals have also begun 
performing them. The participating hospitals were chosen based on the amount of 
procedures performed and the willingness to participate. Not all hospitals were able 
to provide data on all requested parameters, such as fluoroscopy or cine KAP or FT 
or total imaging time. Ethical permission was received (T72/2016), and the request 
for patient consent was waived due to the observational and anonymized setting. 
The initial distribution of collected procedures and difficulty levels is shown in 
Table 1, which was formed based on input from cardiologists and other experts from 
multiple hospitals. 
Table 1.  Initial distribution of proposed bolded procedure types and difficulty levels. 
Coronary procedures Pacemaker 
Implantations 
Electrophysiological 
procedures 
TAVI procedures 
CA Single chamber PI Atrial fibrillation Transapical 
Elective PCI Dual chamber PI  AVNRT Transfemoral 
ad hoc PCI CRT  Atrial flutter  Transaortic 
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The gathered data contained a portion collected with excel sheets, which contained 
descriptive parameters presented in Table 2 and a portion collected from radiation 
dose registries, which contained varying amounts of parameters but was mainly 
limited to total KAP and FT. In total, data from 21 278 procedures were collected in 
Publication I. 
 
Table 2.  Collected descriptive parameters in the data with excel sheets. 
Patient age Patient weight 
Patient height Patient gender 
Fluoroscopy time Total imaging time 
Fluoroscopy dose Cine dose 
Amount of Cine series Air kerma 
 
 
With the excel sheets, a questionnaire was sent to outline the use of personnel 
shielding, typically used projections and collimation, and KAP meter errors as 
reported by regular maintenance. The KAP meter errors were accounted for in all 
publications. 
In both Publications I and II, the DRLs were calculated as third-quartile values 
of the hospitals' medians for the quantity in question, which is in line with the ICRP 
recommendations (ICRP, 2017) and methodology of the Finnish authority (STUK) 
for the new DRLs (STUK, 2016). In the EU-wide data collection (Publication II), 
Finnish data were combined with data from 11 other European countries (Belgium, 
Croatia, Czech Republic, France, Greece, Ireland, Poland, Serbia, Spain, Sweden 
and Switzerland). In total, the data in Publication II were gathered from 14922 
procedures. The descriptive parameters were the same as for Publications I and II. 
In addition to the above analysis methods, an uncertainty analysis was performed to 
account for the varying KAP meter errors and the effect of each country's median 
value on the European DRL. The former was performed using available correction 
factors or nationally mandated maximum errors, whereas the latter was calculated 
separately for each procedure. 
4.1.2 Statistical and machine learning analyses 
In Publications I and II, DRLs were calculated from the third quartiles of the 
hospitals' median values in accordance with the ICRP's 135 recommendations 
(ICRP, 2017). Mainly, the amount of data was also in accordance with the 
recommendations. To study parameters predicting KAP in Publication I, for the 
cases where complete data were available, Spearman correlation coefficients with 
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95% confidence intervals (95% CI) calculated using Fisher's z transformation were 
used in the four procedure categories of coronary procedures, pacemaker 
implantations, electrophysiological procedures and TAVIs. For binary variables 
(patient gender, previous bypass surgery and cardiologist fellow or trainee), a 
Kruskal-Wallis test was performed to test the differences between the groups. An 
AHA classification was treated as an ordinal variable ranging from low to high 
difficulty and from a low to high radiation dose. 
Two-tailed tests of significance (95% CI) were performed to assess the dose level 
differences between hospitals and how they deviated from the national median. Due 
to the assumption of normality, the dose data were transformed with natural 
logarithm and normality was checked with histograms. Even after the 
transformation, several procedures performed in UH2 (CA, PCI and PI) were 
conspicuous as having anomalously high numbers of low doses, but generally, the 
data were deemed sufficiently normal. Dose level differences between different 
procedures or between hospitals were tested with t-tests for independent samples. 
The statistical analysis methods in Publication I were selected based on the 
amount of obtained data and their variance. Statistical power was not calculated 
before data collection. Statistical analyses were performed by an experienced 
statistician using SAS System for Windows, Version 9.4 (SAS Institute Inc., Cary, 
NC). No data imputation was carried out and only some obvious typos were removed 
from the data. 
In Publication IV, features predicting patient KAP in CA and PCI procedures 
were studied with the retrospectively collected cohort data (n=2179) from Turku 
University Hospital's electronic dose and health records using GE DoseWatch 
(GEMS, Milwaukee, USA), the PCI procedure registry (BCB Mecical, Turku, 
Finland) and Uranus (CGI, Montreal, Canada). The timeframe was from January 
2016 to December 2017 and data were collected using a single Siemens Artis Zee 
Ceiling (Siemens Healthcare, Erlangen, Germany) with the dose data corrected with 
the latest dosimeter accuracy report. The only inclusion criterion was availability of 
information on both the DoseWatch and PCI procedure registry of each procedure. 
The feature selection methodology consisted of nine statistical filter-based methods, 
which are independent of the regression model and, as such, are less prone to 
overfitting (Guyon and Elissee, 2003), and an SVR supervised machine learning 
model. The nine filter-based methods were F-value regression (FREG), mutual 
information regression (MIR), SURF (SURF), SURFstar (SURFS), MultiSURF 
(MSURF), MultiSURFstar (MSURFS), Pearson correlation coefficient (PEAR), 
Spearman correlation coefficient (SPEA) and ReliefF (RELF). 
In order to not discard many of the parameters, missing data were imputed with 
the median value when not directly implicit in the data (such as in the case of yes-
or-no questions). The data were first randomly split into training data (80%) and 
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testing data (20%). Categorical features in the data were one-hot encoded, and all 
features were scaled logarithmically to optimize the performance of the regression 
model. Pair-wise Spearman correlations between the features were checked. 
The included 59 patient demographic and clinical features are shown in Tables 
3 and 4. Of the procedures, FN1AC denotes coronary angiography (CA) and FN2BA 
PCI with stent. Of the diagnoses, I35.0 denotes non-rheumatic aortic valve stenosis, 
I20.81 other angina pectoris (AP) with constricted coronary artery (stenosis), I21.01 
ST elevation myocardial infarction (STEMI) involving the left main coronary artery, 
I21.11 STEMI involving the right coronary artery and I21.41 non-ST elevation 
myocardial infarction (NSTEMI) with stenosis. Of the indications, UAP denotes 
unstable angina pectoris. Previous CABG refers to a previous coronary artery bypass 
grafting. Body surface area was calculated with the Du Bois formula (DuBois, 1916) 
and body mass index (BMI) using the standard formula. The number of procedures 
denotes the number of billed procedures performed. Pre-stenosis refers to stenosis 
before PCI and post-stenosis to stenosis after PCI. Chronic total occlusion (CTO) 
refers to long-occluded coronaries and LM unprotected to the unprotected left main 
coronary in the procedure. The AHA score refers to AHA/ACC lesion classification. 
Additional stenting 1 refers to the use of 2 stents and additional stenting over 1 to 
the use of more than two stents.  
Table 3.  Numerical features assessed in Publication IV. 
Feature Unit Mean SD Min Max % missing 
Age years 69.8 11.7 33 97 0.0 
Weight kg 82.2 16.8 44 176 0.0 
Height cm 172 9.3 142.5 194 27.1 
BSAa m2 1.9 0.2 1.4 2.8 27.1 
BMIb kg/m2 28.2 4.9 18.3 50.0 27.1 
Stent dimension mm 3.3 0.6 2.2 5.6 74.9 
Ball dimension mm 3.2 0.8 1.0 5.2 84.1 
a Body surface area 
b Body mass index 
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Table 4.  Categorical features assessed in Publication IV. 
Feature Categories % missing 
Gender male/female 0.0 
Procedure FN1ACa or FN2BAb 0.0 
Indication PCI in STEMI, Flap failure, NSTEMI, 
Diagnostic, UAP, Heart failure, STEMI other, 
Stable AP or Arrhythmia settlement 
19.9 
Coronary segment LADa, LADb, LADc, LCXa, LCXb, LCXc, 
LD1, LM, LOM1, RCAa, RCAb, RCAc, RPD 
35.7 
Diagnosis I35.0c, I20.81d, I21.01e, I21.11f or I21.41g 0.0 
Multi-vessel disease yes/no 0.0 
Previous CABGh yes/no 0.0 
AHA/ACC scorei A, B1, B2 or C 50.2 
CTOj yes/no 0.0 
Restenosis yes/no 0.0 
LM unprotected yes/no 0.0 
Pre-stenosis 60%, 85% or 100% 51.7 
Post-stenosis 0%, 25%, 60%, 85% or 100% 51.7 
Additional stenting 1 or over 1 0.0 
Number of procedures 1, 2 or 3 0.0 
a CA 
b PCI with stent 
c Nonrheumatic aortic (valve) stenosis 
d Angina pectoris 
e ST elevation myocardial infarction (STEMI) involving left main coronary artery 
f STEMI involving right coronary artery 
g Myocardial infarction without ST elevation 
h Coronary artery bypass grafting 
i American Heart Association/American College of Cardiology 
j Chronic total occlusion 
After preprocessing the data, the nine filter-based methods were used to obtain 
rankings for the best features, which were then used as inputs for the SVR. The 
number of features varied from 5 to 40 to assess each methods' accuracy. The mean 
square error (MSE) was selected as the loss function that was minimized. A margin 
of tolerance " was also determined and no penalty was associated in the loss function 
with points predicted within a distance " from the actual value. In addition, since 
SVR does a linear prediction on the data, a radial basis function (RBF) kernel was 
used to transform the parameters into hyperparameters. In Publication IV, radial 
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basis function (RBF) kernel was used. The SVR model was implemented using 
scikit-learn (v0.20.3) in Python (3.5.3) (Pedregosa et al., 2011). 
Before initiating the SVR, various parameter combinations were studied using 
grid search by iterating over all the possible combinations of the given grid. The 
performance of each hyperparameter combination was evaluated using 5-fold cross-
validation on the training data and calculating a validation MSE for each fold. The 
mean error over all 5 folds was then selected as the performance metric of the given 
hyperparameter combination and the process was repeated for the next set of 
hyperparameters. Once all hyperparameter combinations had been evaluated, the 
lowest mean error was selected as the optimal set of hyperparameters for the given 
n features. The SVR model was then refitted on the whole training set using these 
hyperparameters. Finally, the fitted model was used to make predictions on the test 
set with the same n features, and the test MSE was calculated based on the test 
predictions as the final performance metric. 
An illustration of the data processing pipeline is shown in Figure 7. The 
algorithm was repeated 100 times using a new randomization seed in every iteration, 
which was found to ensure the stability and repeatability of the results. 
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Figure 7.  Overview of data processing pipeline in Publication IV: 1) The data was read into a 
dataframe; 2) split into training and test sets; 3) imputed based on the training set; 4) 
the features were log-scaled; 5) feature selection method (k = 1-9) was used on the 
training set; 6) the highest-ranking features (n = 5, 10,..., 40) were obtained; 7) the n 
features from the method k were used to train a support vector regression (SVR) model 
using hyperparameter grid search with inner 5-fold cross-validation; 8) the SVR model 
was refit on the whole training set using the combination of hyperparameters based on 
the lowest cross-validation mean squared error (MSE); 9) the fitted SVR model was 
used to predict the radiation dose in the test set with the same n features and the test 
MSE was saved. Steps 1-9) were repeated 100 times with a new randomisation seed. 
4.2 Patient skin dose measurements 
Concurrently with the excel sheet collection of KAP values, Gafchromic films were 
irradiated under patients in seven of the hospitals. The films' usage during the 
procedures, storage and transportation were carefully instructed. After irradiation, 
the films were sent to the STUK for calibration and scanning. They were calibrated 
following the methodology presented by Alnawaf et al. (Alnawaf et al., 2010). The 
calibration included the following steps: 
• Estimation of the most suitable radiation quality based on the most-used 
radiation energies 
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• Irradiation of pieces of film with suitable doses with a frequently 
calibrated and measured X-ray device 
• Scan of the calibration data with a dedicated scanner in reflective mode 
• Five measurements of the darkening and background each 
• Fitting of the data 
The participating hospitals were shown how to handle the films with care, store them 
inside a black bag and a cardboard box and position them correctly under the patient. 
After irradiation, these boxes were sent to the STUK, where they were analyzed with 
the Epson Expression 1600 Pro scanner. Initially, ten films were distributed to each 
hospital, but more data were gathered in 2018 at the Turku and Kuopio University 
Hospitals, and a new calibration was performed. The newer films were scanned with 
the Epson Expression 12000XL scanner. 
In the initial calibration, dose amounts 0.1, 0.5, 1.0, 3.0 and 5.0 Gy were used 
with radiation quality defined by the International Electrotechnical Commission's 
(IEC) RQR5 (Commission et al., 1994), a typical radiation quality for diagnostic use 
of radiation. In the newer calibration, dose amounts of 0.1, 0.25, 0.5, 1.0, 1.5, 2.0 
and 3.0 Gy were used. The two calibration fits are shown in Figure 8, and examples 
of irradiated films are shown in Figure 9. The two calibrations were compared with 
t-testing (P<0.05) after logarithmic transformation of the data. 
 
Figure 8.  Gafchromic film calibration as maximum skin dose (MSD) vs. net reflective density 
(NRD). The horizontal lines denote the measurement errors. Left: earlier calibration from 
2016. Right: newer calibration from 2018. Published in Publication III. 
Film darkening due to irradiation was measured using ImageJ (Rasband, 2016). Film 
absorbance or net reflective density was calculated from background and maximum 
darkening as 
 A = log (I0=I), (1) 
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Figure 9.  Examples of irradiated films. Up left: PCI with MSD 377.3 mGy, KAP 53.9 Gy·cm2 and 
air kerma 1277 mGy. Up right: PI with MSD 125.3 mGy, KAP 1.1 Gy·cm2 and air kerma 
127 mGy. Down left: Electrophysiological procedure with MSD 415.4 mGy, KAP 71.5 
Gy·cm2 and air kerma 893 mGy. Down right: TAVI with MSD 3.20 Gy, KAP 120 Gy·cm2 
and air kerma 2104 mGy. Published in Publication III. 
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where I0 is the measured background intensity on the same film and I the measured 
mean intensity of 1 cm2 of maximum intensity. In the calibration, film absorbance 
was then fitted binomially to the irradiated dose and the resulting fit was used to 
determine the corresponding maximum skin dose of patients (Alnawaf et al., 2010). 
Measured maximum skin doses were used to estimate KAP and air kerma alert 
levels if the resulting fit of MSD vs. KAP or air kerma was reasonable and had a 
sufficient amount of data points above 2 Gy MSD. In addition, Spearman 
correlations of MSD with other parameters (Table 2) were calculated, and MSDs 
were compared to maximum local RPAK values obtained from GE DoseWatch and 
Siemens CareMonitor. 
Lastly, an analysis of measurement errors was carried out following the 
methodology detailed by Farah et al. (Farah et al., 2015) and an experienced 
statistician was consulted about its most complex portions. The analysis focused on 
scanner, film-to-film, calibration fit and film dose rate uncertainties. Scanner 
uncertainty was determined by extensively testing the scanner daily for two months 
for long-term homogeneity testing and hourly during measurement days for short-
term homogeneity testing. Film-to-film uncertainty was measured using the 
background values of films from the same batch. Calibration fit uncertainty was 
determined from the slope of the fit at 1.75-2.25 Gy for both the initial and the newer 
calibrations. Film dose rate uncertainty was checked at 0.5, 0.28 and 0.14 mGy/s. 
The angiodevices' KAP-meter display accuracies provided by regular maintenance 
were also accounted for, and all collected KAP-values were corrected accordingly. 
4.3 Heart organ dose measurements 
To measure the heart doses of a TAVI procedure and a pre-procedure CT-scan, RPL 
(GD-352M, 2019) dosimeters with a tin filter and an automatic reader (Dose Ace 
FGD-1000, Asahi Techno Glass Corporation, Chiba, Japan, 2016) were used to 
measure the absorbed doses. The measurements were carried out with brand new 
dosimeters. The reader's calibration was performed with calibration dosimeters 
(GDS-352A) before the measurements as well as with an internal daily calibration 
check before reading the results. The calibration dosimeter's irradiation dose was 6 
mGy free in air with Cs-137. 
To carry out the measurements, an anthropomorphic phantom (ATOM male 
phantom model 701, CIRS, Norfolk, Virginia, USA) was implanted with RPL 
dosimeters to measure radiation absorbed in the heart. In total, 20 dosimeters were 
emptied. Two dosimeters were used as references, nine were used in the CT scan 
and nine in the TAVI procedure. In both the CT scan and the TAVI procedure, the 
dosimeters were placed in three slices in the location of the heart. An example of 
dosimeter positioning is shown in Figure 10; the Figure 10 also shows the used Atom 
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phantom positioned on the GE Discovery MI PET / CT scanner with 64 slices 
(GEMS, Milwaukee, WI), which was used for the CT measurements at Turku 
University Hospital's PET Centre.  
 
Figure 10. Example images of RPL dosimeter positioning inside the ATOM anthropomorphic 
phantom (left), phantom positioning on GE Discovery PET / CT table (middle) and 
phantom positioning on Siemens Artis Zeego table (right). 
The CT scan consisted of a diastolic ECG (R-peak delay 60%), a breathgated heart 
scan and a body scan optimized for TAVI. In addition, anteroposterior (AP) and 
lateral (LAT) scout scans and 10 preparation series for gating at the bifurcation level 
were included in the CT scan. The CT protocols are presented in Table 5. 
Table 5.  Relevant heart CT protocol parameters in clinical use in Turku university hospital PET 
centre GE Discovery MI (GEMS, Milwaukee, WI). 
 Gated heart scan Body scan for TAVI 
Scan type Volume Helical 
kV 120 120 
mAs 470 540 
Noise index NA 15.0 
Slice thickness 0.625 mm 0.625 mm 
Pitch NA 1.375 
Iterative 
reconstruction 
ASiR 40% ASiR 40% 
CTDIvol 29.94 mGy 10.95 mGy 
Gating R-peak delay 60% None 
 
After changing the dosimeters, the rest of the measurements were carried out with 
the Siemens Artis Zeego (Siemens Healthcare, Erlangen, Germany) at the Turku 
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University surgical ward, the angiosystem most used for TAVI procedures at Turku 
University Hospital. The TAVI procedure was estimated from the collected 
parameters for Publication 1, protocol data from the used angiosystem for kV, mAs 
and detector doses. In addition, one year's data from the GE DoseWatch (GEMS, 
Milwaukee, WI) were gathered to estimate how much FL and cine is used in each 
projection. The phantom was positioned so that the dosimeters were irradiated for 
all of the procedure. The positioning of the phantom is shown in Figure 10. The 2016 
Finnish DRL (STUK, 2016) was used as the total KAP of the procedure. The 
parameters for the TAVI procedure are presented in Table 6. Both the CT and TAVI 
protocols are in clinical use. 
Table 6.  Relevant TAVI protocol and procedure parameters as estimated from the collected 
parameters for Publication 1 and local data from Turku university hospital's Siemens 
Artis Zeego and GE DoseWatch (GEMS, Milwaukee, WI). 
Protocol fluoroscopy kV 70 
Protocol Cine kV 81 
Protocol fluoroscopy detector dose 45 nGy/p 
Protocol Cine detector dose 0.240 µGy/fr 
FOV 25 cm 
SID 110 cm 
SOD 70 cm 
OID 15 cm 
Total KAP 90 Gy·cm2 
Most used projection PA 
Second most used projection LAO 10 
Third most used projection RAO 10 
Fluoroscopy dose at most used projection 24.2 Gy·cm2 
Cine dose at most used projection 21.6 Gy·cm2 
Fluoroscopy dose at second most used projection 11.7 Gy·cm2 
Cine dose at second most used projection 9.4 Gy·cm2 
Fluoroscopy dose at third most used projection 8.3 Gy·cm2 
Cine dose at third most used projection 14.1 Gy·cm2 
 
Before the reading, the dosimeters were pre-heated as recommended by Manninen 
et al. (Manninen et al., 2012). The dosimeters were read five times and their average 
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value was used to represent the heart dose. As the system used by Manninen et al. 
(Manninen et al., 2012) was considered to be identical but older, determination of 
uncertainty of the measurements was limited to the repeatability check of the 
background doses and dose reading uncertainty. 
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5 Results 
5.1 Patient KAP doses 
5.1.1 Finnish and European DRLs 
Both Finnish and European data collections became relatively weighted toward 
retrospective data. From the perspective of forming DRLs, this was not a problem, 
but this posed a challenge for further analysis. The amount of data for the descriptive 
parameters is shown in Table 7. 
Table 7.  Amount of data and descriptive statistics for descriptive parameters in Publication I. 
 Amount of data Average Range 
Date of procedure 1001  2014 - 2015 
Patient age 916 66.3 19 - 98 
Gender 917 64.4% male  
Weight (kg) 994 82.0 38 - 164 
Height (cm) 993 171.2 65 - 198 
Previous bypass surgery 
(yes/no) 
999 6.9% yes  
AHA/ACC classification 198 B1  
Fluoroscopy DAP (Gy·cm2) 716 12.3 0 - 165.0 
Cine DAP (Gy·cm2) 662 26.9 0 - 794.4 
Number of acquisitions 758 14.0 0 - 108 
Air kerma (mGy) 938 605.3 1 - 11162.5 
 
Initially, dose levels of all the proposed difficulty levels were checked. As a result 
of the t-tests, differences between elective and ad hoc PCI and single and dual 
chamber pacemaker implantations were not statistically significant and the difficulty 
Materials and Methods 
 43 
levels were combined. As for TAVI difficulty levels, the transapical access route 
was so overwhelmingly popular that all difficulty levels had to be combined. In 
addition, of the electrophysiological procedures, AF had significantly higher doses 
than AVNRT or atrial flutter. After discussing the matter, the concept of difficulty 
levels was dropped from the publication. The final procedure categorization is shown 
in Table 8. 
Table 8.  Final procedure categorization in Publication I. 
Coronary procedures Pacemaker 
Implantations 
Electrophysiological 
procedures 
TAVI procedures 
CA PI AVNRT TAVI 
PCI CRT Atrial llutter   
  Atrial fibrillation  
 
In Figure 11, the dose levels of various hospitals in Finland are shown. As mentioned 
in Chapter 4.1, DRLs were calculated as the third quartiles from hospitals' medians for 
each procedure. Because of the low amount of data, some results shown in Figure 11 
were excluded from DRL calculations. Namely, CH 1 was excluded from the PI DRL 
and UH4 was excluded from the PCI DRL. Not all the procedures were given a DRL. 
Namely, for CRT, AVNRT and atrial flutter procedures, the number of hospitals that 
provided sufficient data was too low to calculate the DRL in accordance with the ICRP 
103 (ICRP, 2007), and tentative KAP values were used instead. 
Published KAP DRLs and FT third quartiles calculated similarly to DRLs are 
shown in Tables 9 and 10. The approach with FT was chosen due to its complex 
relation to KAP (Chapter 2.2.) and to recommendations by ICRP (ICRP, 2017). The 
tables also include comparable data from other published results in the literature. 
In addition, Figure 12 shows how TAVI doses decreased in Finland during the 
data collection period. Although the reported Spearman correlation in Publication I 
was not statistically significant (-0.082, P=0.151), it supports the notion of a learning 
curve. 
With good statistics in the t-tests, many hospitals deviated significantly from the 
total data median in CA procedures. Likewise, UH1 deviated significantly from the 
total data median in TAVI procedures. 
Dose variation in the countries that participated in the study published in 
Publication II is shown in Figure 13, which illustrates that dose variation is most 
pronounced in high-dose studies like PCI and TAVI and is even greater at the 
international scale than in Finland. 
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Figure 11. Cardiological patient KAP doses in Finland as published in Publication I. 
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Table 9.  Published and relevant comparison KAP (Gy·cm2) DRLs in Publication I. 
Publication / 
procedure 
CA PCI PI CRT AVNRT Atrial 
flutter 
AF TAVI 
Publication I 30 75 3.5 22b 6b 16b 25 90 
Finnish DRL 
2006c 
60 100       
Sentinel, EU, 
2008d 
45 85       
RAD-IR, USA, 
2003e 
83 193       
Switzerland 
DRL 2018f 
50 100 5  EF 20 RFA 
30 
 100 
Ireland DRL 
2008g 
46.5 106.5 16.9      
Croatia DRL 
2009h 
32        
Bulgaria DRL 
2012i 
40        
Greece 75th 
percentiles 
2013j 
53 129 36   RFA  
146 
  
Pantos et al 
averages 
2009k 
39.9 78.3   EF 14.5 RFA 
54.6 
  
Norway DRL 
2010l 
21        
Australia DRL 
2014m 
58.6 129       
2nd RA’ ACT 
France DRL 
2017n 
26 60       
UK DRL 
2009o 
29        
a (STUK, 2016)   i (Zotova et al., 2012) 
b Tentative DRL calculated as DRLs. j (Simantirakis et al., 2013) 
c (STUK, 2005)   k (Pantos et al., 2009) 
d (Padovani et al., 2008)  l (Statens strålevern, 2010) 
e (Miller et al., 2003a,b, 2012)  m (Crowhurst et al., 2014) 
f (BAG, 2018)   n (Georges et al., 2016) 
g (D'Helft et al., 2008)  o (Hart et al., 2009) 
h (Brnic et al., 2009) 
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Table 10.  Published and relevant comparison fluoroscopy times (min) in Publication I. 
Publication / 
procedure 
CA PCI PI CRT AVNRT Atrial 
flutter 
AF TAVI 
Publication Ia 6.0 18.4 6.7 20.5 13.3 23.1 14.0 21.5 
Finnish DRL 
2006b 
8 20       
Sentinel, EU, 
2008c 
6.5 15.5       
RAD-IR, USA, 
2003d 
5.4 18.5       
Switzerland 
DRL 2018e 
8 20 5  EF 10 RFA 9  30 
Ireland 
averages 
2008f 
4.3 14.5 6.6      
Croatia DRL 
2009g 
6.6        
Bulgaria DRL 
2012h 
5.1        
Pantos et al 
averages 
2009i 
4.7 15   EF 9 RFA 
45.8 
  
2nd RA’ ACT 
France DRL 
2017j 
4 11       
UK DRL 
2009k 
4.5 13 8.2      
a 3rd quartile values calculated similarly to DRLs.   
b (STUK, 2005)    
c (Padovani et al., 2008)   
d (Miller et al., 2003a,b, 2012)   
e (BAG, 2018)    
f (D'Helft et al., 2008)   
g (Brnic et al., 2009) 
h (Zotova et al., 2012)   
i (Pantos et al., 2009) 
j (Georges et al., 2016) 
k (Hart et al., 2009) 
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Figure 12. How TAVI doses have changed in time in Finland as published in Publication I. 
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Figure 13. Distribution of total PKA (KAP) values for each country. The data are for CA (a), PCI (b), 
TAVI (c), PI (d) and EF (e) procedures as published in Publication II. 
Materials and Methods 
 49 
 
 
Figure 13. Distribution of total PKA (KAP) values for each country. The data are for CA (a), PCI (b), 
TAVI (c), PI (d) and EF (e) procedures as published in Publication II (continued). 
5.1.2 Features and parameters predicting KAP dose 
According to the calculated Spearman correlations, the statistically significant 
parameters for the total radiation dose in Publication I, in order of correlation, were 
the amount of cine, FT, patient weight, AHA classification, patient height, 
angiosystem age and patient age. FT, as mentioned above, had a varying correlation 
depending on how much cine was generally taken in the procedures. This was 
especially true for all high-dose procedures, in which the amount of cine correlated 
strongly with total KAP. For TAVI procedures, weight was the most descriptive of 
the above factors. Low correlations of AHA score in CA procedures and angiosystem 
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age in all procedures and negative correlations of patient age in PI procedures were 
noteworthy. 
In the Kruskal-Wallis test, male gender was an influential and significant factor 
for total dose in all procedure types (χ2 = 68.56 with p<0.001 for coronary 
procedures; χ2 = 13.33 with p<0.001 for pacemaker implantations, χ2 = 4.72 with 
p<0.05 for electrophysiological procedures and χ2 = 7.08 with p<0.01 for TAVI). In 
addition, a patient's previous bypass surgery had a significant but minor effect on 
dose in coronary procedures (χ2 = 6.81 with p<0.01). A cardiologist fellow or trainee 
performing the procedure had no significant effect on the total radiation dose. This 
was the case for all procedure types. 
As demonstrated in Publication IV, features predicting the use of radiation in 
coronary procedures are shown in Figure 14. Pair-wise Spearman correlations 
occurred mainly with demographic features and between some diagnoses and 
indications, as shown in Figure 15. 
 
Figure 14. Boxplot showing the feature rankings (range 0-58 from best to worst) from 9 different 
filter-based feature selection methods (9 methods x 100 repetitions = 900 rankings per 
feature) in estimating the treatment radiation dose. The features are ordered by their 
median value based on the rankings. Boxes show the interquartile ranges (IQR) with 
median values (notch) and whiskers show 1.5 interquartile ranges from the lower and 
upper quartiles. Outliers are plotted as individual points beyond the ends of the whiskers. 
The ten highest-ranking features organized by their aggregate median values were: 
1) FN1AC, 2) FN2BA, 3) weight, 4) Post-stenosis 0%, 5) multi-vessel disease, 6) N 
of procedures 3, 7) pre-stenosis 100%, 8) AHA score C, 9) prestenosis 85% and 10) 
gender. The first two emphasize the well-established division between CA and PCI, 
as noted above. Patient weight is a traditional radiation dose predictor and its high 
rank was also expected. 
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Figure 15. Diagonal correlation matrix showing the pairwise Spearman's correlation coefficients 
between different features. 
Post-stenosis 0% is associated with higher KAP (mean 36.7 Gy·cm2 compared to 
mean 28.0 Gy·cm2 for the whole data set) and was ranked fourth. This association 
may be due to the required finesse and subsequent imaging to achieve said result. 
Multi-vessel disease and the high number of performed procedures (3) ranked fifth 
and sixth, respectively, and they are associated with higher radiation doses as they 
directly increase the extent and urgency of the procedure. A high number of 
procedures, however, is strongly correlated with performing PCI. Pre-stenosis 100%, 
AHA score C and pre-stenosis 85% were ranked seventh, eighth and ninth, 
respectively. They all imply difficult procedure with high pre-stenosis and tortuous 
or degenerated vein grafts. 
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Patient gender was ranked tenth, with men on average induced to 32.5 Gy·cm2 
compared to 18.8 Gy·cm2 among women. This difference is partly attributable to 
cross-correlations with patient weight, additional stenting over 1, multi-vessel 
disease, number of procedures 3 and PCI. All of these point to men in Finland 
seeking treatment at a later stage of disease, and, compared to women, more must be 
done to treat them. 
AHA score B1 ranked 11th, but B2 and A ranked significantly lower. The AHA 
score accounts for lesion location, bifurcation, size and shape and coronary tortuosity 
and angulation. These factors describe PCI complexity in terms of outcome and the 
result indicates that its applicability to procedure difficulty in terms of use of 
radiation is not straightforward. 
BSA ranked 12th and was most likely affected by its high correlation to weight. 
CTO ranked 13th, which is lower than expected, and the result was likely affected 
by the low amount of CTOs (32) and huge dose variations among them (mean dose 
69.4 Gy·cm2 and standard deviation 56.3 Gy·cm2). Additional stenting ranked 14th 
and 20th for one and more than one, respectively. Additional stenting implies 
difficult stent placement and that additional imaging is needed to place further stents. 
Results from the prediction performance analysis are shown in Figure 16. They 
indicated differences in suitability for dose prediction for the methods, as well as 
clear dependence on the number of included features. The best performing methods 
were FREG, MIR, PEAR, RELF and SPEA and 30 features was interpreted as a 
suitable number for the methods to perform optimally. 
 
Figure 16. (a) Heatmap showing the mean test errors from support vector regression (SVR) model 
in estimating the treatment radiation dose. The values show the mean test error from 
100 repetitions using the stated number of highest-ranking features from each feature 
selection method. In addition, the mean test errors using the highest-ranking features 
from aggregate votes are shown at the bottom (TOPN). (b) Lineplot showing the mean 
and dispersion of validation and test errors with the number of highest-ranking features 
from all feature selection methods. The faded areas show the 95% confidence intervals. 
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5.2 Patient skin doses 
5.2.1 Measured skin doses and alert levels 
In Publication III, alert levels for TAVI KAP and air kerma were proposed as 200 
Gy·cm2 and 2000 mGy, respectively. The highest measured MSD for TAVI was 
2564 mGy. The second highest doses were measured for PCI, with the highest 
measured dose at 1507 mGy. TAVI and PCI MSD vs. KAP and air kerma are shown 
in Figure 17 and, as shown, PCI has a large KAP vs. MSD variation at high doses. 
In addition, Figure 17 hints at how TAVI doses are divided into two groups as the 
distance between the measurement points and the fitted line both above and below 
the line increases with KAP. Upon further analysis, two of the hospitals had much 
higher doses than the other three, as noted in Table 11, which shows the median and 
SD for MSD and the median for KAP values for the hospitals. Table 11 also shows 
the amount of collected Gafchromic film dosimetry data. Maximum MSD values 
were 377.27 mGy for CA, 941.68 mGy for PCI, 187.16 mGy for PI, 235.98 mGy for 
CRT, 415.35 mGy for AVNRT, 322.99 for AF and 4158 mGy for TAVI. Due to the 
interhospital variation for TAVI, hospital-specific alert levels were estimated at 160 
Gy·cm2 and 2000 mGy for KAP and air kerma, respectively, for both hospitals 1 and 
2. 
 
Figure 17. TAVI and PCI MSD vs. KAP and air kerma in Finland as published in Publication I. 
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Table 11.  Median, amount of data (n) and SD for MSD (mSv) and median for KAP (Gy·cm2) values 
for the hospitals in Publication III. 
Hospital Data Median MSD (mGy) Median KAP 
(Gy·cm2) 
MSD SD 
Coronary procedures 
H1 12 114.1 55.4 15.5 
H2 4 237.0 376.0 23.7 
H3 19 284.2 272.4 34.3 
H4 2 182.7 134.1 11.4 
H5 4 131.9 102.6 24.4 
H6 14 127.0 203.5 23.9 
H7 8 97.2 48.8 21.7 
Pacemaker implantations 
H1     
H2 1 62.8   
H3 10 119.8 48.2 1.3 
H4 1 90.9   
H5 2 149.9 69.5 1.7 
H6 2 140.2 97.2 14.5 
Electrophysiological procedures 
H1     
H2 1 112.2   
H4 1 323.0   
H5 4 109.0 124.9 13.0 
H6 4 142.4 156.0 23.3 
TAVI procedures 
H1 10 1329.5 714.4 88.3 
H2 6 1026.9 1519.0 80.0 
H4a 4 289.7 127.0 92.1 
H4b 9 164.0 211.8 24.4 
H5 5 173.5 57.3 76.7 
H6 4 126.2 131.9 29.0 
a Siemens Axiom Artis dFA in 2016   
b Siemens Artis Zeego Q in 2018    
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Table 12 compares measured skin doses to published values. As seen in the table, 
there is a large variation among studies but the results from this study are mostly 
very reasonable, with the exception of TAVI, which, as noted in Chapter 2, has very 
little published data. 
5.2.2 Commercial skin dose mapping tools 
GE DoseWatch and Siemens CareMonitor MSD estimates were compared to 
Gafchromic film dosimetry results in H1 and H4. These results are shown in Figure 
18. For GE DoseWatch maximum local RPAK, a linear fitting of the data suggests 
the equation 
 MSD = 1.1092 x RPAK + 7.4575, (2) 
 
and for Siemens CareMonitor, it suggests 
 
 MSD = 0.8582 x RPAK + 49.811. (3) 
 
Figure 18. Measured MSD vs. maximum RPAK of GE DoseWatch (H1, n=20), Siemens 
CareMonitor at H1 (n=7) and Siemens CareMonitor at H4 (n=9) as published in 
Publication I. 
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Table 12.  Comparison of mean MSD results (mGy) to various relevant publications as presented 
in Publication III. Amount of data in brackets. 
 CA PCI PI CRT AVNRT AF TAVI 
Publication III 
(mean) 
116 (36) 405 (17) 96 (9) 122 (5) 159 (7) 210 (3) 624 (38) 
a 159 (114) 505 (25)      
b 280 (44) 1030 (33) 30 (36)  170 (21)   
c 504 
(2590) 
976 (947)      
d 351 
(9100) 
1304 
(5294) 
     
e  1482 (20)      
f 158 (90)       
g 103 (16) 526 (12)      
h 210 (39) 491 (25)      
i 264 (158) 596 (63)      
j       290 (15) 
a (Quai et al., 2003)  
b (Trianni et al., 2005)   
c (Crowhurst et al., 2014), converted from RPAK to MSD using formula published by Teeuwisse et 
al. (Teeuwisse et al., 2001)   
d (Pantos et al., 2009), total samples   
e (Greffier et al., 2017)   
f (Didier et al., 2019)   
g (Pasquino et al., 2018) 
h (Kulkarni et al., 2019)   
i (Saeed, 2017) 
j (Karambatsakidou et al., 2016) 
 
5.2.3 Uncertainty analysis 
Scanner long term repeatability uncertainty was estimated as 1.5% and 1.4% for 
Epson Expression 1600 Pro and Epson Expression 12000XL (Seiko Epson 
Corporation, Suwa, Japan), respectively. Scanner short-term repeatability 
uncertainty was 0.8% and 0.1% for the same scanners, respectively. The film dose 
rate response uncertainty was 0.6%, and film-to-film response uncertainty was 4.3%. 
Calibration fit uncertainty was 18.3% and 6.7% for the initial and newer calibrations, 
respectively. The differential analysis for the two calibrations showed that the slope 
of the newer calibration is 10.4% higher with the maximum difference at range 2.0 
to 2.5 Gy. Reference air kerma uncertainty for the used calibration system was 1.0%.  
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Above uncertainty values were reasonably well in line with those reported by 
Farah et al. (Farah et al., 2015), with calibration fit uncertainty for the old calibration 
being the exception. Estimating the missing sources of uncertainty with literature 
values (Farah et al., 2015) (choice of fit for calibration 2%, amount and range of 
calibration data points 2% each, radiation quality dependence 2%, air kerma rate 
measurements 0.8% and beam uniformity 0.3%), total standard uncertainty was 
estimated as 19.3% for the initial calibration and 9.1% for the new calibration, within 
the 20% realistic estimate proposed by Farah et al. (Farah et al., 2015). 
5.3 Heart organ doses related to TAVI 
The mean heart dose from the CT scan was measured as 54.9 mGy and from the 
TAVI procedure as 25.5 mGy. The measurements' ranges and standard deviations 
are shown in Table 13. Table 14 shows relevant comparison values for a chest area 
CT angiography with a 64 slice scanner. However, none of the comparisons includes 
the body scan recommended by the Society of Cardiovascular Computed 
Tomography (Blanke et al., 2019). For a more accurate comparison, the heart organ 
dose can be estimated using literature values (Huda et al., 2010). Calculating the 
heart organ dose from a body CT scan with a dose level of Finnish DRL (STUK, 
2013) results in 19.2 mGy, which explains much of the noted difference in Table 13. 
Calculating heart organ doses with the two CTDIvol values of the performed scans 
results in 59.6 mGy, which agrees well with the measurements (Huda et al., 2010). 
Table 13.  Measured heart organ doses related to a TAVI procedure in Turku university hospital. 
Irradiation Mean dose Range Standard deviation 
CT scan 54.9 mGy 49.5 – 59.7 mGy 2.9 mGy 
TAVI procedure 25.5 mGy 18.7 – 32.4 mGy 5.5 mGy 
 
Heart organ doses for TAVI have not been previously published. For PCI, Brambilla 
et al. recently used the Monte Carlo program PCXMC 1.5 (STUK, Helsinki, Finland) 
(Servomaa and Tapiovaara, 1998) to calculate a median heart organ dose of 90.4 
mGy based on data from 31 procedures with comparable KAP values (median 56.8 
and 3rd quartile 76.5 Gy·cm2) (Brambilla et al., 2017). Compagnone et al., on the 
other hand, reported median heart organ doses of 45.74 mGy (KAP 114.96 Gy·cm2) 
for 75 PCI patients, similarly estimated with a Monte Carlo method (Compagnone 
et al., 2011). These differences in the obtained result of 25.5 mGy can likely be 
attributed to the observed variance in dose levels and used projections. 
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The background radiation dose in the annealed dosimeters was measured as 15.6 
mGy. The dosimeter coefficient of variance was 19.9 %, which is in line with the 
low-dose (20 mGy) reproducibility value of 12.2% published by Manninen et al. 
(Manninen et al., 2012). Read-out uncertainty was measured as 0.2 %, which agrees 
with the literature values of 0.3% by Manninen et al. (Manninen et al., 2012) and 
0.55% by Hsu et al. (Hsu et al., 2006). 
Table 14.  Comparison to relevant published organ doses (mGy) for CT angiography. 
Study Organ Organ 
dose 
(mGy) 
Type of 
scan 
Area kV Slices Gating 
This study Heart 54.9 Volume + 
helical 
Heart + 
body 
120 64 Diastolic 
a Heart 30.5 Helical Heart 120 64 Diastolic 
a Heart 15.8 Volume Heart 100 280 Diastolic 
b Heart 27.8 Helical Heart 120 64 Retrospective 
b Lung 17.6 Helical Heart 120 64 Retrospective 
c Lung 21.8 Volume Heart 120 64 Prospective 
b Breast 25.5 Helical Heart 120 64 Retrospective 
a (Einstein et al., 2010)  
b (Fink et al., 2011)   
c (Khan et al., 2014) 
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6 Discussion 
In cardiological procedures, the focus is always on patient survival and treatment of 
the possibly lethal disease. In all interventional use of radiation, decisions to utilize 
FL or cine are made instantaneously based on procedure status and learned best 
practices. In time, physicians' image quality preferences and personal priorities may 
change, e.g., with musculoskeletal pain due to ergonomic factors (Orme et al., 2015), 
expertise and stress level. As such, creating a safe and optimized culture of radiation 
hygiene is very important in interventional departments. In practice, this means 
continuous optimization, audits, and awareness of risks and good practices of all 
interventional staff. In this regard, guidelines prepared by the STUK (Järvinen et al., 
2018a) are highly valuable to the contemporary Finnish IC scene. 
In this thesis, the contemporary practice of radiation use in IC has been studied. 
This task is clearly visible in the KAP level variation between hospitals and 
countries, but it is intriguingly complex in its causes. Regardless of how this question 
might seem in some hospitals, it is important to approach it with a clear view of the 
whole situation.  
The results presented in this thesis investigate the most relevant radiation risks 
to patients in contemporary cardiology and what issues affect it. As such, the results 
will help optimize clinical practice and support scientific work in the future. 
6.1 Published diagnostic reference levels 
In this thesis, the DRLs first published by the STUK (STUK, 2016) have been 
explored and compared to other published DRLs. With the data and methodology 
presented in both Publications I and II representing contemporary practice, the 
results provide a clear view into which procedures are the most important for 
radiation protection professionals and why. The results also emphasized the well-
known need to regularly update DRLs because, by the time the new DRLs were 
published, the 2006 DRLs (STUK, 2005) were far higher than the dose levels of all 
participating hospitals. 
In both Publications I and II, the DRLs were calculated as third-quartile values 
of the hospitals' medians for the quantity in question, in line with the ICRP 
recommendations (ICRP, 2017) and the STUK methodology for the new DRLs 
Jukka Järvinen 
 60
(STUK, 2016). As mentioned in Chapter 2, traditionally, DRLs have been published 
as either the third-quartiles of the whole data or of the hospital medians, and this 
methodology is not always accurately reported (Georges et al., 2016). Compared to 
the dose levels calculated as the third-quartiles of the whole data, the new Finnish 
DRLs (medians of hospital third quartiles) were 30% lower on average. This 
difference, due to the methodology, was in line with the results published by Georges 
et al. (Georges et al., 2016).  
DRLs are essential optimization tools, especially at the onset of the procedure, 
when extensive local dose data is not yet available. Of special interest before the 
study were the TAVI DRLs, which were among the first DRLs in the world. The 
resulting DRL for TAVI was the highest among the investigated procedures, and as 
such, the procedure was given further emphasis in the analysis. Similarly, the 
tentative KAP value for CRT procedures was among the first published in the world, 
and it was unfortunate that the amount of data did not allow for setting a DRL. 
However, even the tentative value proved interesting, as the value was so much 
higher than the DRL for PI. In the literature, CRT implantations are often treated as 
PI, but this is not advisable according to the published result. A similar effect was 
noticed in the electrophysiological procedures, which are also commonly grouped 
together in the literature (Simantirakis et al., 2013). 
As explained in Chapter 2.2.1, estimating patient cancer risk requires significant 
estimations. Regardless, effective doses and absolute and relative cancer risks are a 
valuable tool in communicating radiation doses and their significance to the public. 
As shown in the results, radiation doses in cardiology vary between several and 
hundreds of Gy·cm2 for the various procedures considered in this study. Continuing 
with the example of cancer risk increase for PCI mentioned in the review of the 
literature, the absolute increase in cancer risk in Finland can be estimated to be 
between 0.002% and 0.2%. However, this estimation does not account for the 
significantly higher average age of IC patients compared to the populations used for 
effective dose calculations, and the actual increase might be even lower. 
Nonetheless, compared to the often-lifesaving benefits of the procedures, this 
increase from a single procedure can be considered small. 
Comparing individual hospitals reveals the above-mentioned room for 
optimization also in Finland. Even as the national variation can be considered 
reasonable in Finland, TAVI and PCI procedures have an especially large 
interhospital dose variation, which likely reflects differences in practice. Whereas 
TAVI is a relatively new procedure in many hospitals, PCI is a traditional and well-
known procedure, the variety of which supports the recommendation for the use of 
difficulty levels (ICRP, 2017). 
In other procedures, compared to PCI and TAVI, the interhospital variation is 
reasonable with CA and CRT having the next-highest variations. However, 
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compared to the non-interventional use of radiation in medicine with relatively well 
standardized studies, e.g., CT, the variation is relatively high. In Publication II, some 
electrophysiological procedures also had high variations between countries, which 
can likely be attributed to differences in procedure methodology. 
Traditionally, differences in dose levels have also been largely attributed to 
angiosystem age (e.g. Gislason-Lee et al., 2016). However, as suggested by the 
results, this interpretation is insufficient. Even as new equipment potentially 
provides a significant boost in image quality and lower doses per pulse or frame, the 
magnitude of the boost varies and, sometimes, optimization work is carried out later, 
which disrupts the correlation. In addition, it is not always the case that these result 
in lower KAP, but rather in more demanding procedures instead. As such, even 
though angiosystem age had a statistically significant correlation to KAP in coronary 
and pacemaker procedures, the correlation was modest. In addition, TAVI 
procedures had a trend of slowly falling KAP, which might also disrupt the 
correlation for angiosystem age. The trend suggests a need for the re-evaluation of 
KAP levels in a few years and use of difficulty levels. 
6.2 Predicting features and difficulty levels 
IC patient KAP prediction and estimation of difficulty levels is a vast topic that is 
dependent on contemporary practice. The results obtained in this study can be an 
important part of a roadmap toward more accurate KAP comparison and 
personalized dosimetry. For coronary procedures, the division to CA and PCI and 
patient weight (ICRP, 2017) alone are not sufficient to predict IC KAP accurately. 
In addition, due to its subjectivity and inaccuracy of the scoring (Klein et al., 2008), 
using the AHA score to predict radiation use is relatively complex. Similarly, the use 
of patient weight or FT alone to describe procedure difficulty has been discouraged 
by the ICRP (ICRP, 2017) and the results presented in this thesis support this 
discouragement. 
Besides CA/PCI and weight, multi-vessel disease, high pre-stenosis, gender, 
CTO or additional stenting can be seen relevant in predicting high radiation dose in 
coronary procedures. CTO in particular has a lower rank than expected based on 
studies such as (Pavlidis et al., 2016; Sakano et al., 2017; Tran et al., 2015) and 
Publication II. This may be due to the rarity of the CTO and whether all CTOs were 
noted correctly in the data. These results should be validated in a multi-center cohort 
study. In addition, the applied machine learning methodology can also be applied to 
other procedures, such as TAVIs, or optimization problems, such as which practices 
most affect KAP and what demographic or clinical factors affect these practices the 
most. 
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As for the obtained results on features predicting the use of radiation in TAVI 
procedures, it can be speculated that perhaps the main reason patient weight was the 
most descriptive factor (excluding fluoroscopy and cine KAP) was the low use of 
projections. With few options for better prosthesis visibility for bigger patients, 
better image quality templates are used. Unfortunately, if the protocols are not 
carefully optimized for different sizes of patients, this choice can significantly 
impact KAP. 
In addition, as noted in the results for skin dosimetry, all collected TAVI doses, 
including KAP, were divided into two groups with two of the hospitals having higher 
doses than the other three. According to the performing cardiologists, this result was 
likely due to differences in methodology and access route. Likely, as suggested in 
Publication III, the result was partly because of the amount of data, but along with 
image quality and the level of protocol optimization, a number of other aspects also 
affect this variation, i.e., used techniques, distribution and optimized use of 
collimation, cine, zoom and 3D imaging also affect this variation. As such, TAVI 
procedures are a good subject for further studies on dose prediction. 
6.3 Patient skin doses 
In the results, Finnish IC skin doses and the available methods to monitor them have 
been presented. The highest skin doses were measured in TAVIs and alert levels of 
200 Gy·cm2 for KAP and 2 Gy for air kerma were proposed for them. In the Finnish 
interventional use of radiation, a traditional alert level of 200 Gy·cm2 for early 
erythema has been used in many hospitals and departments in various diagnostic and 
therapeutic treatments. Based on the results presented in this thesis, this alert level is 
relatively accurate even today. Considering the KAP level and modest variation of 
projection, the resulting skin doses in TAVIs were not a surprise. With the exception 
of PCI, other procedures in IC are unlikely to exceed the 2 Gy level for early transient 
erythema. 
Compared to other published results (noted in Chapter 2.2.4 as well as 
Publication III), the measured Gafchromic film dosimetry MSD values are 
reasonable. Although the measured mean doses are relatively low compared to the 
published limits for erythema (Balter et al., 2010), it should be recognized that it is 
entirely possible for individual cardiological procedures to have much higher doses, 
especially if the patient suffers from chronic total occlusion (Pavlidis et al., 2016; 
Tran et al., 2015). This was also the case in this study, as the noted maximum MSDs 
were much larger than the hospital medians. 
The noted interhospital variation in TAVI procedures in Publication III was 
interpreted to suggest a need for hospital specific alert levels as earlier recommended 
by Järvinen et al. (Järvinen et al., 2018b). As such, indicative hospital specific alert 
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levels were estimated for two of the participating hospitals with significantly lower 
KAP levels (160 Gy·cm2 vs. 200 Gy·cm2). Besides KAP level, the most significant 
factor in this result is the use of projections, which was modest in the two hospitals. 
Relevant personnel in both hospitals were noticed of the result. 
In practice, the optimal use of skin dose estimates is the immediate oral and 
written relaying of information to patient and health records. Although the above 
alert level of 200 Gy·cm2 is sufficiently accurate for general purposes, for individual 
patients and procedures, the variance in the MSD vs. KAP results is huge and is 
mainly attributable to changes in the use of projections. This and other relevant 
parameters are commonly considered by commercial skin dose mapping tools. As 
such, they can be seen to have great potential for personalized dosimetry. However, 
the tested mapping tools also have significant variations compared to the measured 
MSDs. As such, more information on vendor algorithms and estimations especially 
on patient geometry in various procedures should be publicly available and more 
independent studies on them should be carried out. 
Total uncertainty of the measurements was estimated to be well within the 
proposed level of 20% by Farah et al. (Farah et al., 2015). The largest single 
uncertainty was estimated to result from calibration fit, which comprised of 95% of 
the total error for the initial calibration. For the newer calibration, this error was 
much more reasonable. The main reason for the big fit uncertainty for the initial 
calibration was that there are only five data points. An increasing number of data 
points and utilizing RQR7 instead of RQR5 would improve the calibration in the 
future. 
6.4 Heart organ doses related to TAVI 
Heart organ doses due to related CT scans and TAVI procedures were simulated and 
measured after the work on the publications was completed. Although unpublished, 
these measurements add to the comprehensive nature of the study and the breadth of 
utilized methodologies. 
Even as CTA DLPs have been reported to have fallen internationally by 80% in 
the past decade (Stocker et al., 2018), the measured heart doses were quite 
surprisingly mainly comprised of dose from the CT scan (68% of the total dose). 
Compared to new guidelines from the Society of Cardiovascular Computed 
Tomography (Blanke et al., 2019), the protocol used by the Turku PET Centre 
deviated by performing the gated heart scan with a volume scan method and by its 
method of gating. With a 64-slice scanner, a helical acquisition with a retrospectively 
ECG-gated image reconstruction is recommended. With diastolic gating, aortic root 
dimensions are commonly smaller than in the systole, and systolic imaging is 
recommended (Blanke et al., 2019). 
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Besides these deviations from the recommendations, the results also suggest 
looking into the image quality of the scans, even after accounting for the body scan. 
Accordingly, the likely need for the optimization of the CT protocol has been raised 
with the medical physicists at the Turku PET Centre and the cardiologist responsible 
for them. However, it should be noted that the CT scan is a crucial part of the 
lifesaving procedure for relatively elderly patients, whose prognosis without a 
successful procedure is not very good. Thus, optimization that interferes with the 
procedures should be avoided. 
Compared to the CT scan, the heart dose from the TAVI procedure itself had a 
larger standard deviation and range, which can be interpreted to result from the 
positioning of the dosimeters and from far less projections. In comparison to the PCI 
literature values, the measured TAVI procedure heart organ dose was small. 
However, due to only a few published results and differences in procedure and 
measurement methodologies, these comparisons are quite rough. 
Compared to typical organ doses from diagnostic studies or angiographic 
procedures, the total heart organ dose of 80.4 mGy can be relatively high. However, 
due to TAVI's lifesaving nature, some perspective should perhaps be drawn from 
radiation therapy, in which heart organ doses below 40 Gy are often considered safe 
(Grimm et al., 2011). 
6.5 Future prospects of radiation use in cardiology 
In the future, personalized dosimetry is likely to develop and more and more 
sophisticated and accurate methods to evaluate and optimize radiation doses will 
emerge. This will apply to procedure KAP, skin doses, and procedure staff doses as 
well as to other medical uses of radiation. 
Beyond dosimetric advances, the image quality of angiographic systems is likely 
to keep increasing with software and hardware innovations. Angiographic systems 
are bound by the temporal resolution desired by the doctors, and this has long set 
limits as to what kinds of image quality algorithms can be implemented. To 
circumvent them, various sophisticated techniques to optimize and speed up the 
calculations have been steadily introduced to the market and with the pace image 
quality algorithms have been developing, even algorithms utilizing some forms of 
iterative reconstruction or machine learning should not be considered as impossible 
to implement in the future, even in angiography. Likewise, technological advances 
regarding both X-ray detection and output will continue to play an important role in 
improving image quality and lowering the required radiation dose. Lastly, the use of 
shielding and its targeting will likely also improve resulting in both lower staff 
exposure and lower physical burden. 
Discussion 
 65 
These changes will be the most pronounced in the most complex procedures, 
where most radiation is used. However, with the help of optimization tools and 
methodologies such as those presented in this thesis, it is quite possible that some of 
the effects will also affect how radiation is used in more common cardiological 
procedures today. As such, to keep up, monitoring and optimizing the use of 
radiation in this field is a task that will likely continue to evolve and accelerate for 
the foreseeable future. 
Thanks to multinational groups and programs, such as the European radiation 
dosimetry group (EURADOS) and European Joint Programme for the Integration of 
Radiation Protection Research (CONCERT), scientific research in the field already 
has and will continue to improve. With well funded and organized scientific projects 
such as the ongoing Implications of Medical Low Dose Radiation Exposure 
(MEDIRAD) (Cardis et al., 2017) and Validation and Estimation of Radiation skin 
Dose in Interventional Cardiology (VERIDIC) (Malchair et al., 2018), knowledge 
on radiation protection and its optimal implementation will continue to increase. 
What we do with that knowledge largely defines us medical physicist working in the 
field.     
 
 66
7 Summary/Conclusions 
In this study, patient exposure to radiation in IC has been studied in the Publications 
and the measurements of KAP, skin doses and TAVI heart organ doses. Radiation 
dose levels in contemporary practice in Finland have been shown to be relatively 
low compared to many European countries. In all participating countries, the dose 
variation was significant, especially in TAVI and PCI procedures. In this study, 
features explaining this variation in PCI procedures were explored, and patient 
weight, multi-vessel disease, high pre-stenosis, gender, CTO and additional stenting 
indicated a possible high radiation dose. 
The highest doses in contemporary IC in Finland and Europe are in TAVIs and 
PCIs, and skin erythemas can also be concluded to be highly unlikely in any other 
IC procedures. Especially TAVI procedures contemporarily warrant alert levels, 
such as those recommended in this study. However, algorithms such as GE 
DoseWatch and Siemens CareMonitor appear highly promising in estimating patient 
skin dose and are likely to prove accurate and common enough to replace KAP or 
air kerma alert levels in the future. 
Heart organ doses in TAVI appear to be significantly increased by the necessary 
CT scan before the procedure, and the need and ways of optimizing it have been 
discussed in this study. With careful optimization, this increase can be diminished. 
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